Enduring Behavioural Effects in Rats Treated with Caffeine During Adolescence by Anderson, Nika Louise
  
 
 
 
ENDURING BEHAVIOURAL EFFECTS IN RATS 
TREATED WITH CAFFEINE DURING ADOLESCENCE 
 
 
A thesis submitted in partial fulfilment of the requirements for the Degree 
of Master of Science in Psychology 
by Nika Anderson 
 
 
University of Canterbury 
2009 
 
 
 
 
 
  
 
Acknowledgements 
 
 
This thesis, quite literally, would not be in existence without the amazing support, guidance 
and persistence of my supervisor, Professor Rob Hughes. Thank you Rob, for all you have 
done over the past couple of years, it has been truly appreciated. Also, thanks to my co-
supervisor, Dr. Anthony McLean. 
 
To Lara Aitchison, thank you for all the teaching and mentoring you have given me 
throughout this thesis.  
 
Thanks also to the animal technical staff for all the behind-the-scenes work they do for 
research such as this. It is much appreciated.  
 
My parents don’t get acknowledged or thanked enough for all the unconditional support they 
provide. I thank them now for all they have done to get me to this point. I am forever grateful 
for their encouragement, interest and belief in me.  
 
To all my friends and family, thanks for bearing with me, and for your encouragement. 
 
And Greg, thank you for the support of every kind you have given me, for putting up with 
me, and for offering to read this whole thesis (and nearly succeeding)! 
 
  
 
ii 
 
 
Table of Contents 
Acknowledgements .................................................................................................................... ii 
Table of Figures ....................................................................................................................... iv 
List of Tables ............................................................................................................................ iv 
Abbreviations ............................................................................................................................. v 
Abstract ...................................................................................................................................... 6 
1.0 Introduction ......................................................................................................................... 2 
1.1 General Overview ........................................................................................................... 2 
1.2 Caffeine ........................................................................................................................... 3 
1.2.1 Known Effects of Caffeine in Rodents ...................................................................... 6 
1.2.2 Anxiogenic Effects of Caffeine in Humans ............................................................... 6 
1.2.3 Caffeine and its Interactions with Other Social Drugs .............................................. 8 
1.3 Anxiety............................................................................................................................. 9 
1.3.1 Assessing Anxiety in Rats ....................................................................................... 10 
1.3.2 Open-Field ............................................................................................................... 13 
1.3.3 Emergence Test ....................................................................................................... 15 
1.4 Adolescence ................................................................................................................... 16 
1.5 Rationale for Current Study ....................................................................................... 19 
2.0 Aims and Hypotheses of this Study .................................................................................. 20 
3.0 Methods ............................................................................................................................. 21 
3.1 Subjects ......................................................................................................................... 21 
3.2. Caffeine treatment....................................................................................................... 21 
3.3 Behavioural testing ....................................................................................................... 22 
3.4 Open field Test .............................................................................................................. 22 
  
 
iii 
 
3.5 Emergence tests ............................................................................................................ 23 
4.0 Statistical Analyses ............................................................................................................ 24 
5.0 Results................................................................................................................................ 25 
5.1. Open-field and emergence tests at postnatal days 72–82 and 112–122 .................. 25 
5.1.1. Adolescent caffeine treatment effects ..................................................................... 25 
5.1.2 Differences between the two sexes and testing ages ............................................... 28 
6.0 Discussion of Results ........................................................................................................ 31 
6.1 Methodological Limitations ......................................................................................... 34 
6.2 Methodological Strengths ............................................................................................ 35 
7.0 General Discussion ........................................................................................................... 36 
7.1 Availability of Caffeinated Products .......................................................................... 36 
7. 2 Adolescence .................................................................................................................. 37 
7.3 Anxiety........................................................................................................................... 39 
7. 4 Impulsivity ................................................................................................................... 40 
7.5 Escape Behaviours........................................................................................................ 41 
8.0 Suggestions for Future Research ..................................................................................... 42 
9.0 Conclusions ....................................................................................................................... 46 
References ............................................................................................................................... 48 
Appendices ............................................................................................................................... 58 
 
 
 
  
 
iv 
 
 
Table of Figures 
 
Figure 1: Experimental models of anxiety widely used in rodents .......................................... 45 
 
 
 
List of Tables 
  
Table 1: Mean (± S.E.M.) values of each open-field and emergence test measure (except 
urination) for both sexes and testing ages combined following adolescent caffeine treatment, 
and results of ANOVAs. .......................................................................................................... 25 
 
Table 2: Mean (± S.E.M.) values of each open-field and emergence test measure (except 
urination) for males (n = 25) and females (n = 27) and for postnatal days 72-82 and 112-122 
(adolescent caffeine treatment groups combined), and results of ANOVAs. .......................... 27 
 
Table 3: Mean (± S.E.M.) values of four open-field measures for males (n = 25) and females 
(n = 27) recorded at postnatal days 72-82 and 112-122 (adolescent caffeine treatment groups 
combined) for which sex x testing age interactions were significant ...................................... 30 
 
  
 
v 
 
 
Abbreviations 
 
 
C  Celsius 
CNS   Central nervous system 
DSM-IV-TR Diagnostic and Statistical Manual of Mental Disorders (4th Edition, Text 
Revision) 
GABA γ-amino-butyric acid 
GAD  Generalised anxiety disorder  
i.p.  Intraperitoneal injection 
lx  Lux 
mg  Milligrams 
mg/kg  Milligrams per kilogram  
min  Minutes 
ml/kg  Millilitres per kilogram 
mm  Millimetres 
oz  Ounces 
PND  Postnatal days 
PTSD  Post-traumatic stress disorder 
s  Seconds  
S.E.M  Standard error of the mean 
SES  Socioeconomic status 
US  United States of America
  
 
vi 
 
 
Abstract 
Children and adolescents are regular consumers of caffeine, and their consumption is 
increasing. Caffeine has been shown to affect the later behaviour of rats and mice when 
exposed to the drug daily before birth and during the lactational period of development. 
However, to date, little research has investigated the effects caffeine consumption may have 
on adolescent brain development, and the behavioural consequences of this.  The present 
study, therefore, investigated the effects of repeated caffeine exposure on adolescent rats on 
behavioural measures of anxiety. During middle and later adulthood, the rats’ activity and 
emotional reactivity were assessed by means of frequencies of rearing, ambulation, 
immobility, defaecation and urination recorded in an open field, as well as their occupancy of 
corners and centre squares of the field, and their partial emergence and latencies to fully 
emerge from a small darkened chamber into a brightly lit arena. The results showed that those 
rats treated with caffeine were probably more emotionally reactive than untreated controls, as 
suggested by more immobility, defaecation and urination. There were also effects on rearing 
and ambulation that might have arisen from increased impulsivity. Overall, the results 
suggest that exposure to caffeine during adolescence produces some small but significant 
increases in emotionality in adulthood. This study may have clinical implications, as it is 
possible that people exposed to caffeine as adolescents, may show increased anxiety later in 
life. 
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1.0 Introduction 
1.1 General Overview 
Not only is caffeine one of the most widely consumed psychoactive drugs (Hughes, 1996; 
Liguori, Hughes, & Grass, 1997; Nehlig, Daval, & Debry, 1992; Weinberg & Bealer, 2001; 
Zahn & Rapoport, 1987); people as young as 15 years old begin consuming this substance on 
a regular basis (Hughes & Hale, 1998). Much is known about the effects of caffeine exposure 
in human prenatal stages, in neonates, and in adults, but there has been little research 
undertaken in this area on children and adolescents (Heatherley, Hancock, & Rogers, 2006; 
Hughes & Hale, 1998). A large US study in 1982 (cited in Hughes & Hale, 1998) surveyed 
1135 five- to 18-year-olds, and found that 98% consumed caffeine at least once during the 
surveyed week. Their average daily intake was 37mg/day (or .9mg/kg/day).  A later study 
found lower caffeine intake than previous estimates and a greater amount of this caffeine was 
consumed in the form of carbonated drinks (Ellison, Singer, Moore, Nguyen, Garrahie, & 
Marmor, 1995). As with adults, the large majority of children and adolescents are daily 
caffeine consumers. However, both total intake and intake corrected for body weight in 
children are much less than those of adults (Hughes & Hale, 1998).  Thus, it is clear that 
children and adolescents are becoming increasingly exposed to caffeine, but there is little 
known about the short-term and long-term outcomes of this exposure.  
 
An issue when investigating the effects of caffeine on both humans and animals is the 
consistency of dosage. In humans, caffeine is generally self-administered and consumed 
within an everyday diet. Caffeine is found in varying amounts in many different foods and 
drinks (Hughes, 1996), in which doses can vary widely. This can depend on many factors 
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such as beverage type, strength of coffee brew, and beverage size. Some general estimates of 
doses of caffeine are 100mg for 6oz of brewed coffee, 65mg for 6oz of instant coffee, 40mg 
for 6oz of tea, and 35mg for 12oz of soft drinks (Hughes & Hale, 1998). Considering the 
caffeine intake of today’s adolescents, it is important to appreciate that the main active 
ingredient in energy drinks is caffeine. The caffeine content in these drinks varies widely, 
from 50 to 505mg per can or bottle (Reissig, Strain, & Griffiths, 2009). Reissig et al. (2009) 
expressed concern about energy drinks having a high potential to cause acute caffeine 
toxicity due to inadequate labelling of caffeine content and the ease of availability for 
children and adolescents. While energy drinks are not the only source of caffeine for today’s 
adolescents, it is a rapidly growing market (Reissig, et al., 2009).  
 
With the variety of caffeinated products on the market today, and the increasing number of 
adolescents consuming these products, understanding the effects caffeine may have on this 
population seems to be important. To do so, understanding the drug and its mechanisms of 
action is critical. 
 
1.2 Caffeine  
 
Caffeine is a psychostimulant, and one of a group of purine alkaloids (also known as 
methylated xanthines, methylxanthines, or xanthines, Weinberg & Bealer, 2001). When 
consumed, caffeine acts as a stimulant influencing the central nervous system (CNS, Nehlig 
et al., 1992). Caffeine is water soluble and passes easily through cell membranes, including 
the blood brain barrier, (Weinberg & Bealer, 2001) and the placenta (Lorist & Tops, 2003), 
allowing it to affect the CNS. The literature clearly demonstrates that no individual cellular 
mechanism has been found to explain caffeine’s neurochemical action. However several 
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mechanisms have been suggested. Lorist and Tops (2003) have proposed that the CNS effects 
of caffeine are mediated mainly by its antagonistic actions on adenosine receptors. 
Methylxanthines produce effects opposite to those of adenosine through non-selectively 
blocking adenosine receptors, thus reversing the actions of adenosine (Hughes & Hale, 1998). 
 
There are four known adenosine receptors that have been identified: the A1, A2 (A and B) and 
A3 receptors.  The A1 and A2 receptors bind with caffeine at low doses, but the A2B receptor 
only binds at high doses and the A3 receptor is insensitive to caffeine (Fredholm, Bättig, 
Holmén, Nehlig, & Zvartau, 1999). Therefore the A1 and A2 receptors are the most important 
of these receptors in understanding caffeine’s mechanism of action on the CNS (Lorist & 
Tops, 2003). Caffeine’s ability to block adenosine effects on these receptors can be observed 
even at low concentrations, which means its effects can be felt after just a single cup of coffee 
(Lorist & Tops, 2003). Therefore, studying its relevance to both regular and non-regular 
caffeine consumers seems critical.  
 
Of the two adenosine receptors, the A1 receptors are the most prolific in the brain, and are 
found in the highest densities in the hippocampus, cerebellum and cortex (Fredholm, et al., 
1999). Conversely, the A2 receptors are localised in dopamine-rich areas of the brain, in 
particular the striatum, nucleus accumbens, olfactory tubercles and extended amygdala 
(Fredholm, et al., 1999). Adenosine acts pre-synaptically to inhibit the release of  
neurotransmitters such as acetylcholine, norepinephrine, dopamine, γ amino butyric acid, and 
serotonin (Hughes & Hale, 1998). Post-synaptically, the adenosine receptors open potassium 
channels, suppressing neuronal activity (Carlson, 2001).   
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It is suggested that the anxiogenic effects of caffeine may be due to the antagonism of the A1 
adenosine receptors. It is likely that adenosinergic neuromodulation is involved in increased 
emotional reactivity in laboratory rodents after perinatal exposure to caffeine for several 
reasons. Firstly, as discussed earlier, caffeine's acute behavioural effects are most probably 
due to its competitive antagonism of adenosine A1 and A2A receptors (Fredholm, et al., 1999) 
and subsequent facilitation of neurotransmitter activity, especially dopamine (Daly, 1993) 
and acetylcholine (Carter, O'Connor, Carter, & Ungerstedt, 1995).  Secondly, chronic 
treatment with the drug can up-regulate A1 receptors in adult and newborn rat brains 
(Marangos, Boulenger, & Patel, 1984; Saadani-Makki, Frugière, Gros, Gaytan, & Bodineau, 
2004). And lastly, rats exposed to caffeine during both gestation and lactation, show 
heightened sensitivity to acute treatment with adenosine analogues (Fisher & Hughes, 1996). 
Consequently, increased adenosinergic activity is a likely reason for higher perinatal caffeine-
induced emotional reactivity that might be a reflection of greater behavioural inhibition and  
associated timidity (Reznick, 1999).  
 
Dopamine has been proposed as a mediator in the behavioural effects of caffeine, with the 
assumption that caffeine indirectly enhances dopaminergic activity through its antagonism of 
adenosine receptors, in particular the A2 receptors (Garrett & Griffiths, 1997), which as 
discussed above, are found in areas where dopamine is plentiful. Garrett and Griffiths (1997) 
stated that the amphetamine-like profile of caffeine at low doses suggests that dopamine 
could possibly be involved in the subjective effects experienced after caffeine intake. 
Dopamine’s pharmacology changes during the transitions from pre-weaning, to puberty, to 
adulthood in the rat. Consequently, the brain may be susceptible to the effects produced by 
caffeine when administered during adolescence (Andersen, 2003). 
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1.2.1 Known Effects of Caffeine in Rodents 
Caffeine has been shown to affect the later behaviour of rats and mice when exposed to the 
drug daily before birth (Nehlig & Debry, 1994) and during the lactational period of 
development either in their mothers' milk (Hughes & Beveridge, 1991) or via subcutaneous 
injections (File, 1987). A not infrequent result of gestational exposure to caffeine has been 
lower activity detectable soon after birth (Concannon, Braughler, & Schechter, 1983) and 
during adulthood for up to at least 6 months after treatment (Hughes & Beveridge, 1991). 
Similar outcomes have been observed following postnatal exposure during lactation 
(Concannon, et al., 1983; File, 1987; Hughes & Beveridge, 1991) and during both gestation 
and lactation combined (Concannon, et al., 1983; Hughes & Beveridge, 1991). While male 
offspring are more susceptible than females to caffeine treatment during either gestation or 
lactation (Hughes & Beveridge, 1987, 1991; Hughes & Loader, 1996), this sex difference is 
not evident when exposed to the drug during both periods sequentially (Fisher & Hughes, 
1996; Hughes & Hale, 1998). Decreased activity following gestational and/or lactational 
exposure to caffeine has been interpreted as a reflection of heightened emotional reactivity or 
timidity (Hughes & Beveridge, 1987, 1991; Hughes & Loader, 1996). Evidence supporting 
this view includes increased open-field defaecation (Butcher, Vorhees, & Wooten, 1984; 
Hughes & Beveridge, 1991), longer latencies to enter a conditioned aversive environment 
(Sinton, Valatx, & Jouvet, 1981) or to emerge from a darkened chamber into a brightly lit 
arena (Hughes & Beveridge, 1987, 1991), and greater preferences for a black rather than 
white environment (File, 1987). 
1.2.2 Anxiogenic Effects of Caffeine in Humans 
There are differing opinions about the effects caffeine may have on the anxiety levels in 
humans (Smith, 2002). Only a few studies show increases in anxiety following administration 
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of caffeine. However, there remains uncertainty about the direction of the relationship 
between anxiety and caffeine: researchers are as yet, uncertain if caffeine leads to mood 
problems when the person ingesting it already has a high level of anxiety. It has been 
suggested that some people abstain from caffeinated drinks because of the associated 
agitation and anxiety.  In children who do not regularly consume caffeine, high doses of the 
drug can produce unpleasant subjective feelings such as “nervousness, jitterness [sic], 
stomachache, and nausea” (Hughes & Hale, 1998, p.92).  
 
While the study of the anxiogenic effects of caffeine is relatively recent, it has long been 
acknowledged that caffeine can cause symptoms of anxiety (Hughes, 1996). In his review, 
Hughes (1996) stated that consuming caffeine on a regular basis can lead to ‘caffeinism’. 
This presents as edginess, irritability, and tremors, and can be very difficult to differentiate 
from chronic anxiety (Hughes, 1996) without sufficient investigation of the individual’s 
caffeine intake (Andrews, Creamer, Crino, Hunt, Lampe, & Page, 2003; Greden, 1974). 
While it is widely believed that many people consume caffeine in order to experience its 
stimulating effects, some research has raised reservations over this assumption (Stern, Chait, 
& Johanson, 1989, cited in Hughes, 1996; Hughes & Hale, 1998).  
 
While caffeine may indeed cause experiences of anxiety when consumed, it is also capable of 
aggravating the anxiogenic effects of situations which are already associated with stress 
(Hughes, 1996). This phenomenon has been found in animal as well as clinical research 
(Hughes, 1996). For example, physiological concomitants of anxiety such as plasma renin, 
hypertension, elevated corticosterone levels and increased adrenal weights in mice were 
increased by the consumption of caffeine (Henry & Stephens, 1980). Clinically, this is 
important to consider, as it has been reported that in times of stress, caffeine consumption 
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may increase. This may be particularly relevant to the tendency for adolescents and young 
adults to caffeine routinely during stressful periods, such as before school and university 
examinations (Hughes, 1996).  
 
Much research looking at the anxiety-producing effects of caffeine has used very high doses 
which may not replicate normal human caffeine intake (Quinlan, Lane, Moore, Aspen, 
Rycroft, & O'Brien, 2000; Smith, 2002), especially as many studies involve the equivalent of 
a total daily amount of caffeine in one single dose, when caffeine is typically consumed in 
smaller doses over a longer period of time (Smith, 2002). Overall, the literature suggests that 
extremely high does of caffeine may increase acute anxiety, but this is rarely seen within the 
range of normal human caffeine intake (Smith, 2002). This, however, does not address the 
long-term anxiogenic effects of caffeine. Long-term drug effects may in fact be the function 
of a phenomenon known as neuronal imprinting, which posits that the effects of a drug may 
manifest themselves long after exposure to the drug has finished (Andersen & Navalta, 
2004). Therefore, the acute anxiogenic properties of caffeine may be less relevant in this 
study. 
1.2.3 Caffeine and its Interactions with Other Social Drugs 
It has been found that caffeine consumers are more likely to be smokers and consume more 
alcohol (Hewlett, 2006). The finding that alcohol consumption may be increased in caffeine 
consumers has been attributed to the fact that alcohol is a strong inhibitor of caffeine 
metabolism (George, Murphy, Roberts, Cooksley, Halliday, & Powell, 2008), which may 
increase and prolong the positive effects of caffeine intake. Research with adults has found 
that caffeine dependence may be associated with cigarette smoking (Bernstein, 2002), and 
that smokers also consume more caffeine than non-smokers (Reissig, et al., 2009). This effect 
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has been explained, to some extent, by an increase in caffeine metabolism among cigarette 
smokers (Reissig, et al., 2009). Human and animal studies have found that caffeine increases 
the reinforcing properties of nicotine (Reissig, et al., 2009), and thus some researchers have 
expressed concern over caffeine’s potential status as a gateway drug (Bernstein, 2002). 
Bernstein et al. (2002) found that teenagers displaying abuse or dependence of any other drug 
consumed significantly more caffeine than those with no drug abuse or dependence. The 
authors go on to question whether early and chronic caffeine use may establish dependence 
on the drug, and whether it may in fact, facilitate other drug-taking behaviour such as 
nicotine, marijuana and alcohol. 
 
1.3 Anxiety  
 
The experience of anxiety is a normal human phenomenon. In fact, moderate levels of 
anxiety can be valuable in improving performance, and even severe anxiety can be perceived 
as normal in the appropriate situation or context (Andrews, et al., 2003). Anxiety has been 
described as a sense of uncontrollability, during which the individual is predominantly 
focused on future threats, danger or upcoming potentially negative events (Barlow, 2000). 
Once an individual has identified a situation as being a threat, the automatic, physiological 
response is an increase in arousal, leading to action. If action is not possible, the 
physiological arousal is experienced as symptoms associated with the fight-flight response, or 
anxiety (Andrews, et al., 2003). Anxiety symptoms include: heart palpitations, dry mouth, 
nausea, gastrointestinal discomfort, difficulty breathing, hyperventilation, numbness, 
dizziness, muscle tension, trembling, and narrowing of attention (Andrews, et al., 2003; 
Wiedemann, 2001). Lader & Bruce (1986, cited in Hughes, 1996) have stated that the 
  
 
10 
 
negative anxiety symptoms produced by caffeine can be very similar to those characterising 
generalised anxiety. 
 
As anxiety is such a common and costly problem in today’s society, understanding its 
etiology and mechanisms of action seems vital. There are many ways to undertake the 
assessment of anxiety, such as clinical studies, using individuals already seeking medical or 
psychological intervention for their anxiety, or through animal models. Animal models of 
anxiety are based on the assumption that anxiety in animals is comparable to anxiety in 
humans. While it cannot be verified that an animal experiences anxiety in the same or similar 
ways to human beings, it has been observed that rodents display distinct behavioural patterns 
which can indicate anxiety (Ohl, 2003). Some of the methods of assessing anxiety in animals, 
and a number of the limitations of doing so, are discussed below. 
 
1.3.1 Assessing Anxiety in Rats 
Millan (2003) discusses the difficulties in assessing anxiety experimentally. ‘Anxiety’ or 
anxious states, are human descriptions for mood states experienced by people, and therefore 
much inference must take place when undertaking the behavioural study of anxiety in 
animals.  No single operational measure of anxiety exists, however the term ‘emotionality’ 
has been used to describe the anxious state experienced by animals (Archer, 1973). In order 
to study anxiety experimentally through animal models, one must establish some parameters 
which reflect these anxious states. As animals cannot describe the feelings they are 
experiencing, it is consequently up to the experimenter to infer, from their behaviour, the 
mood or  emotional state the animal is going through. Some bodily functions can indicate the 
‘emotions’ animal may be experiencing. Tachycardia (increased heart rate), increase in 
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arterial pressure, and hyperthermia can all indicate anxiety in non-human subjects. However, 
these are often impractical to measure when using animal behavioural paradigms (Millan, 
2003). Behavioural markers in rodents, understandably, look somewhat different to those 
generally exhibited by humans.  
 
As will be outlined below, several observable behaviours in rats have been considered to be 
indices of emotionality. An understanding of these terms in the context of animal models of 
anxiety is beneficial, therefore a brief explanation of some the key behaviours follows: 
- Exploratory behaviour in rodents encompasses a broad spectrum of behavioural patterns 
such as risk assessment behaviours, walking, rearing, climbing, sniffing, and manipulating 
objects (Ohl, 2003).  
- Locomotion is generally measured as the area covered by the animal in a particular test, for 
example in the open field. Locomotion scores do not generally describe any other behaviours 
in which the animal may be engaged, nor do they infer a ‘motivation’ for the locomotion.  
- Freezing refers to sudden immobility, which may last for a specified period of time. 
- Defaecation is generally measured in number of faecal boluses, while urination may be 
measured in volume, or frequency.  
- When a rat stands upright on its hind legs, this is referred to as rearing. In this study, the 
frequency of rearing was measured, as well as the location of the rearing. 
- Emergence latencies refer to the time taken for the subject to emerge from one environment 
to another (generally more aversive) environment.  
 
As discussed above, behavioural markers must be relied upon to reflect the emotive 
experiences of the animal. For example avoidance, escape, and freezing all indicate that an 
animal may be experiencing anxiety, despite the fact that humans do not necessarily display 
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these behaviours when anxious (Archer, 1973; Millan, 2003). Hall (1934) originally related 
emotionality in rats to the level of sympathetic nervous activity, selecting urination and 
defaecation as his primary measures. Many researchers consider exploration or locomotion to 
be inversely related to emotionality (Archer, 1973). Consequently, a motor response, or lack 
thereof, such as freezing, can be interpreted by the experimenter as indicating a particular 
mood state, for example, anxiety (Millan, 2003). Decreased activity following gestational 
and/or lactational exposure to caffeine has been interpreted as a reflection of heightened 
emotional reactivity or timidity (Hughes & Beveridge, 1987, 1991; Hughes & Loader, 1996). 
Evidence supporting this view includes increased open-field defaecation (Butcher, et al., 
1984; Hughes & Beveridge, 1991), longer latencies to enter a conditioned aversive 
environment (Sinton, et al., 1981) or to emerge from a darkened chamber into a brightly lit 
arena (Hughes & Beveridge, 1987, 1991), and greater preferences for a black rather than 
white environment (File, 1987). However, interpretation of these behaviours may be less 
straightforward than commonly thought. For example, Lester (1968, cited in Archer, 1973) 
referring to data from an enclosed maze, suggested that low and high fear states are 
associated with low exploration, whereas at intermediate fear states, exploration is high, thus 
producing a U-shaped curve. Impulsivity, panic response and escape behaviours may also be 
contributing to faster emergence latencies, high locomotion scores and rearing behaviours 
(Evenden, 1999; King, 1999a).  
 
Hughes (1996) discussed the anxiogenic effect of caffeine in its clinical and animal domains. 
As he stated, several studies have proposed that regular consumption of “high doses” (p.37)  
of caffeine, can be related to high levels of chronic anxiety. It was shown using prenatal 
exposure to caffeine in rodents, that the drug can have modest effects on the developing 
brain, which can later have influences on behaviour (Hughes & Beveridge, 1987). 
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Importantly, these authors reported chronic increases in behaviours which are associated with 
heightened emotional reactivity. While this study and others (eg. (Hughes & Beveridge, 
1990, 1991; Hughes & Loader, 1996 ) focused on prenatal or lactational exposure, it is also 
reasonable to expect that the development of the brain during adolescence could be affected 
after exposure to caffeine.  
1.3.2 Open-Field 
In the assessment of emotionality and anxiety, the open field is one of the simplest and most 
popular tests currently in use (Brain & Marrow, 1999). The actual open-field procedure 
normally consists of forcing the rodent to confront an aversive situation (Belzung, 1999).  
“The test consists of the measurement of behaviours elicited by placing the subject in a novel 
open space from which escape is prevented by a surrounding wall. The elicitation of  these 
behaviours is dependent upon the interaction of the animal with a variety of test factors such 
as (a) stimulation as a result of removal from a familiar home environment; (b) stimulation 
involved in transferring the animal to the open field; (c) exposure to the test environment, 
consisting of both the open field itself and its surroundings; and (d) all prior experience of the 
test situation” (Walsh & Cummins, 1976, pp.482-483).  
Behaviours elicited by placing the rodent in this novel environment are measured. Different 
versions of the test are in use, with variations in lighting, shape and the presence of various 
objects placed in the arena (Belzung, 1999). Originally most open fields were circular, but 
square and rectangular designs later became common (Walsh & Cummins, 1976).  
 
The open-field paradigm has been long used as a tool for the study of emotionality. Once a 
rat is placed in the open field, various behavioural measures can be evaluated. Assessment of 
emotionality can include measuring locomotion, ambulation, rearing, freezing, urination and 
defaecation. Rearing, locality and quantity of movement, and defaecation, have all been 
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labelled behavioural measures of emotionality (Archer, 1973; Ivinskis, 1966, 1968, 1970). 
Early research found that more emotional rats exhibited fewer entries in the central part of the 
apparatus, and higher levels of defaecation (Hall, 1934).  
 
Rearing is a behaviour which, while easy to measure, is often ambiguous in its interpretation. 
The experimenter must infer the rearing behaviour’s purpose – normally either as evidence of 
anxiety, through attempting to escape, or as curiosity. One might expect that rearing 
behaviour at the perimeter of the enclosure may be indicating anxiety and an animal’s attempt 
to escape; whereas rearing behaviour in the inner area may be more indicative of curiosity, 
namely exploration of the upper parts of the apparatus. The animal’s presence in the inner 
area itself, would normally indicate decreased anxiety. However, Archer (1973) indicated that 
there is little consistent relationship between centre entries and defaecation in the study of 
emotionality. Most animals do show active escape behaviour as a response to aversive 
stimuli, which may account for jumping and rearing behaviours which have been observed, 
especially close to the walls, and may give support to researchers inferring that these 
behaviours do indeed indicate emotionality (Archer, 1973).  
 
Ambulation is assessed in relation to either lines drawn on the floor or using photocell beams. 
As the rodent passes through each beam or crosses a line, one unit of locomotor behaviour is 
recorded (Brain & Marrow, 1999). Higher counts of locomotion could indicate less anxiety. 
Also, the number of faecal boluses deposited in the field can be counted as a measure of 
anxiety, with increased defaecation indicating higher anxiety (Brain & Marrow, 1999). 
Ivinskis (1966) stated that satisfactory measures of emotionality can be obtained using 
defaecation scores, and a form of urination scoring. The author found that both correlated 
significantly, supporting Hall’s (1934) original findings. However, the methods of measuring 
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urination vary. It is possible to count the frequency of urination, but it is difficult to measure 
the volume of it due to the varying quantities of urine eliminated (Ivinskis, 1966). Ivinskis 
(1966) proposed a urine weighing method to counter this problem, as his study found that 
frequency of urination was an unstable measure over long-term testing. There is also a 
problem in inferring the reason for urination. Body weight, sex and metabolism may all 
contribute to varying urination levels in subjects (Ivinskis, 1968), all of which are seemingly 
unrelated to emotionality. 
 
The open field has been long established as an appropriate test for measuring situational 
anxiety in rodents (Millan, 2003), however, other behavioural tests of emotionality exist. The 
emergence test measures behaviours in a different setting to the open field, hence providing 
additional information about emotionality. This test is discussed further below. 
1.3.3 Emergence Test 
The emergence test is based on rodents’ inherent aversion to brightly illuminated areas and 
on their spontaneous exploratory behaviour response to mild stressors, such as novel 
environment and light (Bourin & Hascoët, 2003). The emergence test consists of a small dark 
start box, which opens out into a larger brightly lit chamber. Access to the lit chamber is 
normally facilitated by the experimenter exposing a gap between the two areas. This then 
creates a natural conflict situation as the animal is exposed to an unfamiliar environment. The 
conflict is between the tendency to explore and neophobia (Bourin & Hascoët, 2003). 
Neophobia is a reaction characterised by a hesitancy to engage with novel objects, places, or 
conspecifics (Paré, Tejani-Butt, & Kluczynski, 2001). The exploratory activity observed 
when a rodent is placed in the emergence test reflects the combined result of these tendencies 
in novel situations (Bourin & Hascoët, 2003). 
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Behaviours considered to be indicative of emotionality in the emergence test differ somewhat 
to those measured in the open field. Two recent studies recorded the following behaviours: 
emergence latency, number of head pokes, and activity (Paré, et al., 2001; Thompson, Li, 
Clemens, Gurtman, Hunt, Cornish, & McGregor, 2004). Emergence latency is recorded at the 
time the rodent fully emerges from the start box into the brightly lit chamber.  Head pokes 
rely on a consistent operational definition, as this behaviour can be somewhat ambiguous. 
Head pokes are generally recorded when the rodent partially emerges from the start box and 
then retreats. Head pokes could be interpreted as either risk assessment behaviour, with risk 
assessment indicating general anxiety (Paré, et al., 2001), or as behaviours demonstrating 
curiosity.  Activity was measured by Paré et al. (2001) as the number of squares in the lit 
chamber traversed with all four feet. These behaviours are easily recordable and measurable, 
and are a good indication of emotionality and neophobia (Paré, et al., 2001; Thompson, et al., 
2004). 
 
1.4 Adolescence 
 
Most caffeine chronically administered to developing rats has taken place either prenatally, or 
very soon after birth. Until quite recently, animal research has not been concerned with 
periadolescence as a period during which there could be vulnerability to substance abuse 
(Smith, 2003).  Some researchers have claimed that humans are the only species to undergo 
the period of adolescence, but as Spear (2000) argues, even adolescent rodents display typical 
signs of adolescence, such as developmental hyperphagia and accelerated growth rates. As 
well as these signs, gonadarche, increases in social interactions and risk-taking activity have 
been exhibited in other animal species during this stage of life, all of which are considered to 
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be indicators of adolescence in humans (Spear, 2000). Other researchers have developed 
working definitions for rodent adolescence (Andersen, 2003; Andersen & Navalta, 2004; 
Smith, 2003). Rats enter late adolescence around post-natal day (PND)45 and this stage lasts 
until approximately PND55 (Andersen, 2003; Andersen & Navalta, 2004). Smith’s definition 
of rat adolescence using the detection of mature diurnal gonadotropin cycling as the indicator, 
suggests that dosing to incorporate all of the adolescent period should include PND28-60. 
Referring to Andersen and Navalta’s (2004) study above, administering caffeine to rats 
between PND45 and 55, comes within Smith’s (2003) definition of adolescence.  
 
The trajectory of mammalian brain development occurs in multiple stages. Research shows 
that the human brain is still developing during the adolescent period, and changes appear to 
continue into the twenties (Winters, 2004). The nucleus accumbens, amygdala and prefrontal 
cortex which undergo maturation during childhood (Winters, 2004), as well as late 
developing structures, including the cortex, hippocampus and the cerebellum (Andersen, 
2003), mean that different brain regions appear to be vulnerable at varying periods of 
development. During the periadolescent period, the brain develops an excess of synapses and 
receptors, which is then followed by synaptic pruning or competitive elimination. This 
developmental strategy has been observed in humans, primates, and rats (Andersen, 2003).  
Steinberg (2005) labels adolescence as a particular period of vulnerability in terms of neural 
systems, and its connections with behavioural and cognitive systems. He suggests that these 
connections are either weak or unconnected at this stage of development, especially as these 
systems mature at different rates. The reorganisation of regulatory systems creates a period of 
neural development which is particularly sensitive (Steinberg, 2005). During pre-puberty 
several neurochemical changes also occur.  Inappropriate stimulation, such as drug exposure 
during these phases, can cause abnormal development, whereas appropriate stimulation 
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during critical periods are necessary for appropriate maturation to occur (Andersen, 2003).  
Due to the complex structural and neurochemical changes which occur during the 
periadolescent to adolescent periods, consumption of some drugs during late development 
may cause different effects from those seen when these drugs are consumed during adulthood 
(Smith, 2003).  
 
The adolescent CNS is known to remain plastic in response to some types of manipulations. 
For example, with alcohol, it has been reported that the developing CNS is even more 
susceptible to alcohol-induced changes during postnatal dendritic elaboration than in 
neurogenesis (Smith, 2003). As dendritic elaboration continues well into adolescent 
development, susceptibility to alcohol-induced brain damage may also continue on in later 
development. Damage to structures such as the frontal cortex, neuronal loss in the 
cerebellum, basal forebrain and neocortex have all also been demonstrated when the 
developing brain is exposed to alcohol (Winters, 2004).  
 
Administering caffeine, or any psychotropic drug during adolescence is of interest as the 
maturation of motor behaviour and mood is fundamentally related to synaptic remodelling or 
enhanced connectivity, both of which occur before adulthood (Andersen, 2003). Andersen 
and Navalta (2004) stated that drug exposure during childhood and adolescence alters the 
development of the areas of the brain which are affected when the drugs are active. There are 
a number of reports describing subsequent effects of a range of drugs administered to rats and 
mice during their periadolescent stage of development, however little is known about caffeine 
in this respect. This is in spite of research showing that a number of other drugs which are 
popular with human adolescents, such as alcohol, amphetamines and “party pills”, can 
influence the course of later behavioural development when administered to adolescent rats 
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(Aitchison & Hughes, 2006; Bergstrom, McDonald, & Smith, 2006; Vorhees, Reed, Morford, 
Fukumura, Wood, Brown, Skelton, McCrea, Rock, & Williams, 2005). In some cases, such 
treatment has resulted in the development of higher levels of emotional reactivity, as 
exemplified by later effects on adolescent rats of a common ingredient of party pills, 1-
benzylpiperazine (Aitchison & Hughes, 2006). In view of such outcomes and the fact that the 
adolescent brain is not fully mature either anatomically or neurochemically (Spear, 2000), it 
would not be surprising if chronic exposure to caffeine during this vulnerable period were to 
interfere with normal brain development, and normal, expected developmental pathways 
could potentially become very different to what would be predicted in normal development. It 
is surprising then, that the long-term effects of caffeine and other drug exposure on the 
immature brain have not been sufficiently studied at either the clinical or preclinical stages 
(Andersen & Navalta, 2004).  
 
1.5 Rationale for Current Study 
Perinatal and immediate post-natal caffeine treatment has been shown to result in  persistent 
behavioural changes, such as hyperactivity, extending into adulthood (Tchekalarova, Kubova, 
& Mares, 2005). Gestational and lactational exposure to caffeine has led to reasonably 
permanent increased emotional reactivity to testing situations (Hughes & Beveridge, 1991). 
Evidently caffeine has both acute and long-term effects on emotionality and behaviour in the 
rat (Hughes, 1996). Recent research has demonstrated that the long-term effects of drug 
exposure are delayed and may be expressed once the vulnerable system reaches maturation, 
often during adulthood (Andersen & Navalta, 2004). Despite the prolific research on 
gestational and perinatal caffeine exposure, little, if any, work has been undertaken 
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investigating the effect of caffeine administered chronically to adolescent rats, and its long-
term effects during adulthood. Likewise, the potentially harmful effects of early drug 
exposure in humans have received little attention (Andersen, 2005).  
2.0 Aims and Hypotheses of this Study 
 
At present, there are no data on the long-term behavioural effects of caffeine administered to 
rodents during adolescence. This study therefore aimed to investigate the effects of caffeine 
after administration during adolescence. As so many adolescents consume caffeine on a 
regular basis, with little known about the long-term effects, the results of this study could 
provide much-needed information in this area.  
 
This study focused on the long-term anxiogenic effects of caffeine. It was hypothesised that 
exposure to caffeine during the sensitive period of adolescence may interfere with normal 
brain development and thus cause long-term increased emotionality in rats. Moreover, it was 
hypothesised that exposure to a higher dose of caffeine during adolescence would be more 
effective than a lower dose.  
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3.0 Methods 
 
3.1 Subjects 
 
The subjects were 27 male and 27 female PVG/C hooded rats chosen from 12 litters, at the 
breeding colony at the University of Canterbury. All litters were of similar size and contained 
approximately equal numbers of each sex. The rats were weaned at 30 days of age, caged in 
groups of 3–4 individuals of the same sex from different litters with free access to food 
(commercial rat pellets) and drinking water. They were kept in an ambient temperature of 
22°C ± 2°C on a 12 hour light/dark cycle (with lights on at 8.00am) . 
 
Procedures for housing, drug treatment and testing of all subjects were approved by the 
Animal Ethics Committee of the University of Canterbury (see Appendix 1). 
 
3.2. Caffeine treatment 
 
When 45 days old (PND45), the 54 experimental subjects were randomly assigned to a 
control (0 mg/kg) group, a group treated with 15 mg/kg caffeine or a group treated with 30 
mg/kg caffeine. These groups contained equal numbers of each sex and, as near as possible, 
equal numbers of rats from every litter. Each rat was then given a daily intraperitoneal (i.p) 
injection (1 ml/kg) of its appropriate dose for 11 consecutive days. Control animals were 
administered isotonic saline, and caffeine-treated rats received caffeine dissolved in saline. 
Although it is recognised that humans consume caffeine orally, the i.p route of administration 
was chosen for ease of delivery. 
  
 
22 
 
3.3 Behavioural testing 
 
All rats were run through three open-field followed by three emergence tests between PND72 
and PND82 (early adulthood), and this process was repeated again between PND112 and 
PND122. There was an interval of three days between each pair of tests at each testing age. 
Exactly 40 days intervened between individual subject's set of tests at the younger and the 
older age. All testing occurred during the light phase of their light/dark cycle in order to 
minimise disruption caused by the rats being brought out of a darkened holding room into the 
illuminated research room. 
 
3.4 Open field Test 
 
The apparatus used was a 600×600 mm wooden open field with walls 250 mm high. It was 
painted black and the floor was divided into 16 squares by a grid of intersecting painted white 
lines. The open field sat on a 700-mm high table and was illuminated by overhead fluorescent 
lighting at 47 lx. An infrared video camera was mounted 850 mm above the floor of the 
apparatus, and all behaviour of each individual rat was recorded for 5 min after having been 
placed in the centre of the open field. The rat was then removed and the number of faecal 
boluses it left in the apparatus (defaecation) and the number of times it had urinated 
(urination) were counted before the field was washed with a 2% solution of Powerquat Blue 
disinfectant. The video tapes were later viewed and the following forms of behaviour 
recorded for each rat: 
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(1) the number of times it reared up on its hind legs (rearing) 
(2) the number of lines crossed by its hind legs (ambulation) 
(3) the number of times it remained completely immobile for more than 3 s 
(immobility) 
(4) the number of 3 second observations (signalled by an auditory timer and 
earphone) in which it was occupying one of the four corners (corner occupancy) or 
four centre squares of the apparatus (centre occupancy). 
 
3.5 Emergence tests 
 
After each rat completed its time in the open-field test, it was returned to its home cage for 
several minutes and was then placed in a small darkened chamber in order to measure its 
speed of emergence into a larger brightly lit arena. The apparatus comprised a 200×150×200-
mm-high black-painted wooden box that opened by means of a sliding door into a 
500×400×200-mm-high arena with a translucent Perspex floor that was illuminated from 
underneath by two 16-w fluorescent tubes. The light level in the arena was 172 lx, and it was 
covered by a wire-mesh lid. The apparatus sat on a 700-mm high table in the same room as 
the open field. An emergence test consisted of placing a rat in the darkened chamber and, 
approximately 10 s later, opening the sliding door to allow it access to the brightly lit arena. 
The number of times it partially emerged was counted (head pokes), and the time it took to 
fully emerge was recorded by a hand-held stop watch. If it had not fully emerged after 5 min, 
the trial was terminated and an emergence latency of 300 s recorded.  
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4.0 Statistical Analyses 
 
Two male control rats died in between the first and second series of open-field and 
emergence testing at PND72–82 and PND112–122. Therefore, treatment (3)×sex (2)×testing 
age (2) ANOVAs were performed on all measures recorded in the open field (except 
urination) and emergence apparatus for the remaining 52 rats that completed testing at both 
ages. As it was clear that there were no consistent patterns of change for any group on any 
measure between the three tests conducted at each testing age, the ANOVAs were carried out 
on individual rats' averages of the three. When significant caffeine treatment effects occurred, 
post hoc comparisons were made between all individual groups by means of Neumann–Keuls 
tests. Because of large numbers of 0 scores and thus highly skewed distributions, urination 
was subjected to nonparametric median tests (Siegel, 1956) to assess the effects of adolescent 
caffeine treatment and sex on numbers of rats that were not seen to ever urinate. An overall  
comparison of urination at the two testing ages was made by means of a sign test (Siegel, 
1956). 
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5.0 Results1 
5.1. Open-field and emergence tests at postnatal days 72–82 and 112–122 
5.1.1. Adolescent caffeine treatment effects 
Mean ± S.E.M scores following adolescent caffeine treatment for all measures recorded in 
the open field (except urination) and emergence apparatus during PND72–82 and PND112–
122 combined can be seen in Table 1.  
Table 1: Mean (± S.E.M.) values of each open-field and emergence test measure (except 
urination) for both sexes and testing ages combined following adolescent caffeine 
treatment, and results of ANOVAs. 
___________________________________________________________________________ 
    Caffeine treatment dose (mg/kg)   
 0 (n = 16) 15 (n = 18) 30 (n = 18) F(2, 46)  p   
_______________________________________________________________________    
Rearing 34.50 (± 2.73)a 28.47 (± 1.86)a,b 35.34 (± 1.68)b       3.40 .042 
Ambulation 73.76 (± 5.04) 64.79 (± 4.67)a 79.32 (± 5.78)a       3.74 .031 
Immobility*   0.96 (± 0.12)a   1.46 (± 0.12)b  2.08 (± 0.43)a,b 10.74   <.0001 
Corner occupancy 50.34 (± 1.75) 54.32 (± 2.62) 53.24 (± 1.78)  0.76     >.4 
Centre occupancy   5.25 (± 0.34)   3.89 (± 0.51)   5.07 (± 0.56)  2.30     >.1 
Defaecation   0.51 (± 0.16)a   1.07 (± 0.37)   1.87 (± 0.43)a  3.45 .04  
Emergence (s)         110.31 (± 18.84) 143.03 (± 18.06)a 66.87 (± 16.51)a     4.47    .017  
Head pokes                 4.40 (± 0.51)a 6.41 (± 0.68)b   3.44 (± 0.41)a,b   7.51 .002 
___________________________________________________________________________
a,b Difference between the two groups with superscripts in common significant, p<.05, 
Neumann-Keuls test.  *Caffeine treatment x testing age interaction significant (see text).
                                                 
1
 Further explanation of the results of this study are outlined in the recently published paper:  
Anderson, N.L. & Hughes, R.N. (2008). Increased emotional reactivity in rats following exposure to 
caffeine during adolescence. Neurotoxicology and Teratology, 30, 195–201. 
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Significant caffeine treatment effects occurred for all measures except occupancy of corners 
or centre squares of the open field. Rats that had been treated with 15 mg/kg caffeine 
exhibited less rearing than those in either other group and less ambulation than rats treated 
with 30 mg/kg caffeine. These latter rats were also more  immobile than those in the other 
groups, defaecated more than control animals, emerged faster from the darkened chamber 
than rats treated with 15 mg/kg caffeine and made fewer head pokes than those in either other 
group. (A significant interaction occurred between adolescent caffeine treatment and testing 
age for immobility, F(2, 46)=4.30, p=.019, and will be described in the next section (5.1.2) 
dealing with sex and testing age differences.). The numbers of rats that did not urinate in the 
open field on any of their six opportunities following adolescent treatment with 0 (n=16), 15 
(n=18) and 30 mg/kg (n=18) caffeine respectively were 5 (31.25%), 3 (16.67%) and 4 
(22.22%). Differences between these groups were not significant, χ2(2)=3.20, p>.2.  
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Table 2: Mean (± S.E.M.) values of each open-field and emergence test measure (except urination) for males (n = 25) and females (n = 
27) and for postnatal days 72-82 and 112-122 (adolescent caffeine treatment groups combined), and results of ANOVAs. 
 
____________________________________________________________________________________________________________________ 
    Sex Postnatal days 
 Males Females F(2, 46)  p 72-82 112-122 F(1, 46)  p  
___________________________________________________________________________________________________________________ 
Rearing 29.31 (± 1.69) 36.85 (± 1.66) 8.64 .005 31.05 (± 1.40) 35.11 (± 1.50) 4.39   .042 
Ambulation* 57.08 (± 3.24) 86.93 (± 3.17)  47.22 <.0001 72.69 (± 2.95) 71.32 (± 3.46)  0.18 >.6 
Immobility**   1.68 (± 0.19)   1.38 (± 0.14)    2.07  >.1   1.83 (± 0.17)   1.23 (± 0.11)     17.72 <.0001 
Corner occupancy* 54.65 (± 1.95) 50.93 (± 1.43) 2.21  >.1 54.33 (± 1.18) 51.25 (± 1.57) 5.76    .021 
Centre occupancy*   4.30 (± 0.40)   5.10 (± 0.41)    1.79  >.1   4.58 (± 0.31)   4.82 (± 0.38) 0.34  >.5  
Defaecation* 1.53 (± 0.31) 0.85 (± 0.29) 2.37 >.1   1.39 (± 0.26)   0.99 (± 0.21) 4.88    .032 
Emergence (s)       120.24 (± 18.02) 93.96 (± 12.92) 1.64        >.2          96.24 (± 11.94)       117.96 (± 11.87) 4.59 .038 
Head pokes                4.84 (± 0.46)   4.69 (± 0.53) 0.05 >.8   4.44 (± 0.36)   5.09 (± 0.44)  2.66 >.1 
____________________________________________________________________________________________________________________ 
*Sex x testing age interaction significant (see text).  **Caffeine treatment x testing age interaction significant (see text). 
27
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5.1.2 Differences between the two sexes and testing ages 
As can be seen in Table 2, female rats showed significantly higher overall frequencies of 
rearing and ambulation in the open field than males. More rearing accompanied by less 
immobility, corner occupancy and defaecation, and longer emergence latencies occurred at 
the older testing age than when the rats were younger.  
 
However, there were also significant interactions between sex and testing age in ambulation, 
F(1,46)=6.06, p=.018, corner occupancy, F(1,46)=10.32, p=.002, centre occupancy, 
F(1,46)=5.46, p=.024, and defaecation, F(1,46)=8.06, p=.007, along with the significant 
caffeine × testing age interaction for immobility referred to in the previous section. The sex × 
testing age interactions are outlined in Table 3.  
 
These revealed significantly more ambulation for females than for males at both testing ages, 
and a significant decrease in the response from PND72–82 to PND112–122 for males but not 
for females. While females occupied open-field corners less and centre squares more than 
males at the older testing age, the two sexes did not significantly differ on these measures at 
the younger age. Females also occupied corners less and centre squares more at the older than 
at the younger age, but this was not so for males.  Males defaecated more than females at the 
younger but not the older testing age, and, contrary to females, defaecated less at the older 
than at the younger age.  
 
The caffeine × testing age interaction for immobility arose from, a significant decrease 
between days 72–82 and 112–122 only for rats treated with 30 mg/kg caffeine i.e., 2.69 
(±0.33) and 1.48 (±0.19) respectively. There were no significant changes between the two 
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testing ages for either the control, F(1,46)=2.44, p>.1, or 15 mg/kg caffeine-treated groups, 
F(1,46)=0.01, p>.9, and the caffeine treatment effect remained significant at testing ages 72–
82, F(2,46)=10.84, pb.001, and 112–122, F(2,46)=4.17, p=.022. Numbers of males (n=25) 
and females (n=27) that did not urinate in the open field on any occasion were 4 (16.00%) 
and 8 (29.63%) respectively. This sex difference was not significant, χ2(1)=1.36, p>.2. For 
both sexes combined, 13 rats urinated less, 17 urinated more and 22 showed no change 
between PND72–82 and PND112–122. These numbers did not differ significantly, z=0.55, 
p>.5. 
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Table 3: Mean (± S.E.M.) values of four open-field measures for males (n = 25) and females (n = 27) recorded at postnatal days 72-82 
and 112-122 (adolescent caffeine treatment groups combined) for which sex x testing age interactions were significant 
 
 
____________________________________________________________________________________________________________________ 
 Males Females 
                                             ____________________________________________       ____________________________________________ 
   Postnatal days 72-82 Postnatal days 112-122 Postnatal days 72-82 Postnatal days 112-122 
____________________________________________________________________________________________________________________ 
Ambulation 59.27 (± 3.36)a,c 54.89 (± 3.70)b,c 85.11 (± 3.30)a,d 88.74 (± 3.51)b,d  
Corner occupancy 54.09 (± 1.62)e,g 55.21 (± 2.67)f,g 54.06 (± 1.75)e,h   47.31 (± 1.43)f,h 
Centre occupancy   4.63 (± 0.39)i,k   3.97 (± 0.52)j,k   4.54 (± 0.48)i,l   5.65 (± 0.51)j,l 
Defaecation   2.04 (± 0.40)m,o   1.01 (± 0.31)n,o   0.79 (± 0.31)m,p   0.91 (± 0.30)n,p 
____________________________________________________________________________________________________________________
a-pValues of F(1,46) and probability levels for comparisons between groups with superscripts in common,  a32.12, p <.0001, b48.92, p <.0001, 
c4.05, p = .05, d2.16, p >.1, e0.04, p >.8, f6.46, p = .014, g0.32, p >.5, h16.49, p <.0001, i0.06, p >.8, j4.91, p = .032, k1.49, p >.2, l4.46, p = .04, 
m6.06, p = 0.018, n0.03, p >.8, o12.36, p <.001, p0.21, p >.6. 
30
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6.0 Discussion of Results 
 
Clearly, exposure of the rats to caffeine during adolescence resulted in a number of 
significant outcomes that would at least justify further research and perhaps question the 
wisdom of consumption of high doses of caffeine by human adolescents. This is because 
treatment with the drug increased immobility and defaecation in the open field thereby 
suggesting that it had produced small but long-lasting increases in emotional reactivity 
(Angelucci, Césario, Hiroi, Rosalen, & Cunha, 2002).  
 
The caffeine treatment also had some complicated effects on ambulation and rearing in the 
open field i.e., the lowest frequencies of each were associated with exposure to 15 mg/kg 
(low dose group) while there was no significant difference between 0 mg/kg (control group) 
and 30 mg/kg (high dose group). Since both measures are believed to be negatively related to 
emotionality (Archer, 1973), this would suggest that 15 mg/kg had increased emotional 
reactivity but that 30 mg/kg was paradoxically ineffective in this respect. However, it is 
possible that while the lower of the two caffeine doses may have indeed increased emotional 
reactivity and thus interfered with any curiosity-related basis for the two responses, the higher 
dose may have similarly increased emotional reactivity and suppressed curiosity but may also 
have initiated fear-induced attempts to escape from the apparatus. This was supported in 
particular for rearing activity by casual observations that this response seemed to reflect 
either a more relaxed curiosity-related “interest” in the upper parts of the apparatus, or rather 
“frenetic” behaviour that gave the appearance of attempts to escape. Obviously further 
research is required to establish whether or not it is possible to distinguish between two types 
of ambulation and rearing in terms of their specific motivational substrates. 
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The finding that the shortest emergence latencies in the emergence apparatus occurred with 
rats exposed to 30 mg/kg caffeine would also appear to be contrary to the possibility that the 
drug had increased emotional reactivity. On the other hand, the fact that the lowest 
frequencies of partial emergence in the form of head pokes also occurred with this group, 
might be interpreted as being due to increased emotional reactivity. However, this seems 
improbable because of a positive Pearson correlation between the two responses for all rats 
combined i.e., r=0.76, p(50)<.001. Instead, as supported by casual observations, it seems 
more likely that both responses reflected an increase in impulsivity that has been shown to 
follow acute caffeine administration in rats (Flora & Dietze, 1993). 
 
Sex differences favouring females in open-field rearing and ambulation for PND72–82 and 
PND112–122 combined were consistent with the view that females are more active than 
males (Archer, 1973). There were also some other sex differences that were dependent  on 
the age at which the rats were tested namely, less corner and more centre squares occupancy 
for females than for males when the rats were tested at PND112–122, but no sex differences 
in these measures at PND72–82. On the other hand, males defaecated more than females 
when tested at the younger age, but not when older. These sex differences were consistent 
with the view that male rats are more emotionally reactive than females (Belzung, 1999; 
Gray, 1971). 
 
Increases in rearing and emergence latencies for all rats between the two testing ages suggests 
that, in line with earlier conclusions (Bessa, Oliveira, Cerqueira, Almeida, & Sousa, 2005; 
Imhof, Coelho, Schmitt, Morato, & Carobrez, 1993), they may have become more 
emotionally reactive as they grew older. This is because they were slower to emerge from the 
darkened chamber of the emergence apparatus and engaged in more possibly escape-related 
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rearing at the later testing age. However, a contrary interpretation would follow the 
observations that, for males only, ambulation and defaecation declined between the two ages, 
whereas corner occupancy declined and centre squares occupancy increased for females 
alone. In addition, immobility also declined only for rats that had been treated with 30 mg/kg 
caffeine. So, while some of the changes suggest an increase in emotional reactivity with age, 
namely rearing (possibly) and emergence latencies, others suggest a decrease as reported 
earlier (Candland & Campbell, 1962; Hughes, 1968; Williams, Carr, & Peterson, 1966) i.e., 
sex-dependent ambulation (possibly), corner and centre squares occupancy, defaecation and 
caffeine treatment-related immobility. Clearly, the behavioural processes underlying these 
different age-related changes can not be conclusively identified without further research. 
 
The effects of treatment with caffeine during adolescence on later immobility, defaecation, 
and perhaps rearing and ambulation suggest heightened emotional reactivity in a similar 
manner to that concluded for the subsequent effects of perinatal exposure to the drug (Hughes 
& Beveridge, 1987, 1991). It is possible that caffeine-treated rats' adolescent experience also 
increased impulsivity (Flora & Dietze, 1993), as suggested by their emergence latencies and 
number of head pokes in the emergence apparatus. Overall, it seems likely that the results of 
the study were due to caffeine effects on adolescent brain development possibly involving 
adenosine-facilitated increases in neurotransmitter activity (Fredholm, et al., 1999), 
especially dopamine (Daly, 1993), comparable to what probably characterises pre- and early 
postnatal development. In addition to having possible implications for the risks of caffeine 
consumption by human adolescents, the results highlight the need in future research to 
determine how critical adolescence really is in this respect, compared to other ages that are 
not commonly regarded as important identifiable stages of brain development. 
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6.1 Methodological Limitations 
There are some methodological limitations to consider before generalising these results. 
Firstly, it is important to note that the rats were administered caffeine via i.p injection. This 
poses a number of different problems. Humans tend to self-administer caffeine, and do so 
orally. This study initially attempted to orally administer rats caffeine, but practically, this 
proved difficult. Adding caffeine to a cage’s drinking water created problems. When 
unadulterated drinking water was measured to create baseline data, different cages consumed 
varying volumes of water. Due to the fact that rats were housed in cages of three, it was not 
possible to measure how much each individual rat consumed. If rats had been housed 
individually this may have been easier to control, however, practically this was not possible.  
 
It has been suggested that the procedure of i.p. injections alone can have an anxiogenic effect 
in mice (Lapin, 1995), which potentially makes the procedure less than ideal.  However, all 
groups, treatment and controls, received their appropriate injection solutions in the same 
manner. Therefore, despite the administration route being imperfect, the effects seen can 
definitely be attributed to the drug and not to differences in administration route.  
 
This study investigated caffeine consumption purely during the period of late adolescence in 
the rat. It is likely that human consumption of caffeine occurs throughout the lifetime, with 
consumption possibly beginning in some children, before the age of five (Frary, Johnson, & 
Wang, 2005). Therefore the period of time during which caffeine was administered is very 
selective and short compared to human patterns of consumption of caffeine. However, this 
study clearly demonstrates the effects caffeine consumption can have in even a very short 
space of time, which illustrates the clinical importance of the findings – that this age period is 
potentially vulnerable to insult and drug use. 
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6.2 Methodological Strengths 
There are advantages to using rats when studying drug effects on behaviour. As these animals 
develop rapidly (Andersen, 2003; Clancy, Finlay, Darlington, & Anand, 2007), the periods of 
adolescence and adulthood occur much more quickly than they do in adulthood . This means 
that the time taken for drug administration and testing is much less than if initial research was 
to be completed on humans.  
 
Although this study aimed to increase awareness about the long-term effects caffeine may 
have on humans, animal subjects were used to predict human responses to the drug. 
Therefore some caution must be exercised when generalising these results directly to humans. 
However, animals can indeed be used to answer questions about behavioural dysfunctions, 
their underlying neural mechanisms and drugs’ effects on behaviour (van der Staay, 2006). In 
addition to this, animal studies can be useful for assessing the behavioural impact of drugs 
which may affect human anxiety levels (Ohl, 2003).  
 
While this study did not exactly mimic the human consumption patterns of caffeine, it has 
described important aspects of the effects of caffeine exposure during adolescence. From the 
results, we can begin to identify the effects that caffeine may have during adolescent brain 
development. The amount of brain development that occurs throughout childhood and 
adolescence is immense, and the potential for long-lasting behavioural effects is evident. This 
study can therefore be seen as important for initiating and guiding future research into this 
freely available and widely used drug.  
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7.0 General Discussion 
The results of this study supported the general hypotheses of this research. Treatment with 
caffeine during adolescence did result in some small but nevertheless significant, long-term 
increases in emotionality. However, there were some complicated findings which show that 
our understanding of this area is far from complete.  
7.1 Availability of Caffeinated Products 
Energy drinks, soft drinks, coffee and tea, are readily available, consumed regularly and often 
in high quantities by adolescents and young people today. All of these beverages contain 
varying levels of caffeine. As a consequence, the percentage of young people consuming 
caffeine today is not only large, but it is increasing (Carlezon Jr. & Konradi, 2004). One 
study, which examined two-day averages of caffeine intake, found that 91% of males aged 12 
to 17, and 88% of females in the same age range consume caffeine (Frary, et al., 2005). The 
effects of repeated exposure to caffeine in young people without awareness of dosage is 
surely worth investigating. There are few, if any, psychotropic drugs other than caffeine, 
which society makes available in such an unregulated (Reissig, et al., 2009) and unlimited 
manner.  
 
The research of Reissig et al. (2009) into currently available energy drinks shows that their 
caffeine content ranges from 50mg to 505mg per can or bottle. Hughes (1996) listed caffeine 
contents for other beverages including ground coffee and coca cola which, in large cups, 
ranged from 3mg (for decaffeinated coffee) to 128mg (for ground coffee). The caffeine 
content of energy drinks appears to be significantly higher than these other beverages, 
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begging the question of why these drinks are allowed to be so heavily marketed towards 
young people, and why there are no regulations on the selling or labelling of these drinks. 
 
There is a well-established relationship between dietary adequacy and socioeconomic status 
(SES), which has been documented in the literature. SES is related to factors such as income, 
education level, occupation, and family size. One particular study has investigated the 
relationship between family SES and the dietary patterns, particularly caffeine intake, of 
children aged 24 to 36 months. Significantly higher caffeine consumption was found in the 
lower SES group at all three stages of the study (Skinner, Carruth, Houck, Morris, Moran, & 
Coletta, 2000). The researchers found that soft drinks, such as cola beverages, coffee and tea 
were the main sources of dietary caffeine in these children. Findings such as these suggest 
that certain sections of society may be at greater risk of adverse effects from caffeine as the 
consumption of caffeine is higher in these groups. Education or prevention may initially need 
to be aimed at these at-risk areas. Education can be provided through parents, dietician 
services (Skinner, et al., 2000), education providers, and through public awareness (Knight, 
Knight, Mitchell, & Zepp, 2004). 
 
7. 2 Adolescence 
As has been discussed, little is known about how caffeine can affect neuronal, structural and 
neurochemical development in the maturing adolescent brain. However, what is known is that 
during other periods of development, such as during gestation and lactation, caffeine 
exposure can result in increased emotionality and timidity, both in the short and long-term 
(Hughes & Beveridge, 1987, 1991; Hughes & Loader, 1996). The adolescent brain is still 
undergoing massive transformations and development (Andersen, 2003; Steinberg, 2005; 
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Winters, 2004), and so one must question then, why caffeine, a drug so prolific and common 
in modern society, is so under-researched in this vulnerable age group.  
 
As rats in this study were administered caffeine only during the period of late adolescence 
(PND45-PND55), one can infer that the behavioural effects seen were due to the drug’s 
effects on brain development during this time. Many areas of the brain are maturing during 
this period, including the nucleus accumbens, amygdala, prefrontal cortex, hippocampus and 
cerebellum  (Andersen, 2003; Winters, 2004). With so much development occurring, the 
vulnerability of the brain to drug effects during this developmental period is clear. It is also 
known that the effects of drugs on the developing brain may not be known immediately 
(Andersen & Navalta, 2004). Therefore, investigating the enduring effects of caffeine on the 
adolescent brain, is important, because it may give a truer picture of what the consequences 
of such drug use could be. The concept of drug effects lasting longer than the drug exposure 
itself, is known an neuronal imprinting (Andersen & Navalta, 2004). It appears that the 
results of this study support the notion of neuronal imprinting. As has been discussed, exactly 
where in the brain this neuronal imprinting has occurred is not yet fully understood, as 
caffeine’s mechanisms of action are not simple.  
 
The implications neuronal imprinting have for drug taking behaviour during adolescence are 
fairly clear. Teenagers are generally unaware of the rapidly occurring changes in their brain 
at the time of drug-taking, and are equally unaware of the potential long-term effects this 
drug-taking may have. When a sanctioned drug such as caffeine is consumed, there is likely 
to be little consideration of the possible long-term consequences this may have for behaviour 
or mood. As caffeine is so prevalent in our diet, and is often not labelled in our foods and 
drinks (Reissig, et al., 2009), it is even possible that adolescents today are consuming caffeine 
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when they are not even aware of it, or are not aware of the quantity of caffeine they may be 
consuming on a regular basis.  
 
7.3 Anxiety 
Emotionality, or emotional reactivity, in the rat is regarded as the animal equivalent to human 
anxiety. This study found small long-term increases in some measures of emotionality in rats 
exposed to caffeine in adolescence. While more animal research would further increase our 
understanding of precisely what might be occurring after adolescent caffeine exposure, there 
is also the need for clinical research into the long-term effects caffeine may already be having 
on humans. Already, anxiety and anxiety disorders are extremely prevalent in modern, 
Western society. Anxiety disorders, as a group, are the most common psychiatric disorder in 
the US (Beidel & Stipelman, 2007), with lifetime prevalence for the group of disorders 
estimated to be as high as 25% (Hettema, Neale, & Kendler, 2001). The acute anxiogenic 
effects of caffeine in humans have been established (Hughes, 1996), as have longer term 
effects in animals when exposed to the drug early in life (Hughes & Beveridge, 1987, 1991).  
 
Many neurotransmitters have been implicated in the initiation and inhibition of anxiety and 
anxious states, including monoamines, γ-amino-butyric acid (GABA) glutamate, adenosine, 
cannabinoids, multiple neuropeptides, hormones, and neurotrophins (Millan, 2003). 
Likewise, several brain structures seem to be involved in the expression of anxiety. The 
limbic system, and in particular, the amygdala, is associated with anxiety (King, 1999b; 
Lezak, Howieson, & Loring, 2004). As noted above, the amygdala is maturing and changing 
during the childhood and adolescent periods (Winters, 2004), which might help explain the 
anxiogenic effects seen in this study. While there are commonalities in the neurobiology of 
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anxiety, the varying anxiety disorders appear to be have some associations with different 
brain structures and chemical pathways. For example, dopaminergic functioning has been 
found to play a central role in social phobia (Stein, 1998). Serotonin and norepinephrine 
among other neurotransmitters, have been implicated in panic disorder (Coplan & Lydiard, 
1998), and GABA seems to be associated with GAD (Connor & Davidson, 1998). Because of 
the complicated neurobiology of anxiety, it is difficult to understand completely where 
exactly caffeine may be exerting its influence. As this study only involved the behavioural 
effects of adolescent exposure to caffeine, it did not endeavour to investigate the specific 
brain areas or neurochemicals affected by the caffeine administration. We can infer, however, 
that the adenosinergic pathways as well as dopaminergic already discussed in this paper are 
likely to have been affected.  
 
7. 4 Impulsivity 
Not only was emotional reactivity increased in rats exposed to caffeine during adolescence in 
this study, but impulsivity was possibly heightened as well. The idea that impulsivity could 
be affected by caffeine exposure had not previously been considered, and is yet to be 
researched in a structured manner. Nevertheless, these behavioural effects are extremely 
important to consider when reflecting on the implications of this research. The DSM-IV-TR 
stated that impulsivity can manifest itself in many ways, including impatience and difficulty 
delaying responses (APA, 2000). Elsewhere, impulsivity has been described as behaviours 
which are poorly thought out, prematurely expressed, unnecessarily risky, or situationally 
inappropriate, and which have the propensity to result in undesirable outcomes (Evenden, 
1999).  
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Adolescents are already more likely to engage in risk-taking behaviours than other age 
groups, and it has been hypothesised that this may have a range of effects, from assisting 
them to gain the necessary skills to allow them to survive without their parents, to 
predisposing some teenagers to the use of alcohol or other drugs (Spear, 2000). Increases in 
impulsivity in this already vulnerable population may result in even more risky behaviours. 
Evenden (1999) believes that there is no one biological basis for impulsivity, and that there 
are consequently varying manifestations of this behaviour. As a consequence, researching 
this area of behaviour may prove somewhat challenging. Nevertheless, based on the results of 
this study, it seems possible that impulsivity may also be a long-term effect of adolescent 
caffeine consumption, and thus warrants further research. 
 
7.5 Escape Behaviours 
In many species, life-threatening events can set in motion a series of primitive behavioural 
and autonomic responses which include freezing, increased heart rate, and endocrine changes 
which prepare the person or animal for a fight-or-flight response. Humans suffering from 
some of the more severe anxiety disorders may experience recurrent unexpected panic attacks 
which may be manifested as persistent symptoms of physiological arousal, including 
hypervigilance, exaggerated startle responses, and accelerated heart rate symptoms, all of 
which suggest the presence of the fight-or-flight state (King, 1999a). 
 
Some of the behaviours observed in the subjects in this study appear to have been driven by 
the rat’s desire to escape from the apparatus. In particular, some of the rearing and 
locomotion behaviours in the open field apparatus among the high dose rats looked 
qualitatively different to other rearing and locomotion behaviours in the other two groups. 
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Some behaviours began as apparently curiosity-motivated rearing behaviour but then changed 
into attempts to climb the open field walls, which may have been more indicative of active 
attempts to escape.  
 
Several behavioural tests have been developed to measure escape behaviours in animals, an 
example of which can be seen when rats are observed in an elevated plus maze. The 
behaviours they exhibit in this apparatus are believed to replicate phobic anxiety states and 
GAD in humans. Whilst this and other tests may successfully replicate several types of 
human anxiety disorders, few behavioural tests have, as yet, been devised which capture the 
“chronically hyper-aroused, highly avoidant, flight-oriented state characteristic of patients” 
(King, 1999a, p.114) suffering from such extreme anxiety states as panic disorder or post-
traumatic stress disorder (PTSD, King, 1999a). 
 8.0 Suggestions for Future Research 
 
As has been discussed throughout this thesis, the present study has highlighted the need for 
future research into the long-term effects of caffeine consumption during adolescence. 
Today’s adolescents consume caffeine in large quantities. However, there is little scientific 
understanding of what long-term effects this consumption may be having on their behaviour 
and mood (Reissig, et al., 2009). To gain a complete understanding of how caffeine may 
interfere with brain development, there are several areas of the study which could be adapted, 
modified or expanded. 
 
Firstly, exposing subjects to a wider range of caffeine doses may provide a clearer picture of 
the long-term anxiogenic effects of caffeine. This may shed some light on some of this 
study’s findings in the open field, in which the high dose group was not significantly different 
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from the control group in scores of ambulation and rearing. Incorporating more groups 
treated with a wider range of doses might identify where, among the varying doses, this shift 
in behaviour occurs.  
 
This leads to another area which could guide future research. Some of the paradoxical results 
found in this study, for example in the open field test, indicated that the measures used for 
emotionality may not capture this construct fully, or take into account other reasons for a 
particular behaviour. This study’s methods did not capture the possibility that impulsivity (for 
example, low emergence latencies in the emergence test) or escape behaviour (for example, 
rearing and ambulation in the open field test) may be driving some of the behaviours seen, 
particularly among the high dose group. Incorporating specific tests of impulsivity and escape 
behaviour in the behavioural test battery may help to identify some of the motivations behind 
these behaviours.  It is possible to look at impulsivity as a construct through animal models. 
One study showed that impulsivity could be seen in animals that showed increased locomotor 
activity in the open field test, but displayed a greater change in behaviour following the 
introduction of a novel object (Evenden, 1999).  Likewise, escape behaviours have been 
researched, and paradigms have been produced to measure these behaviours. An example of 
this was achieved by studying the behaviour of animals in a threatening environment after 
repetitive electrical stimulation of the superior colliculus (King, 1999b).  
 
The period of caffeine administration in this study encompassed 11 days during late 
adolescence, from PND45-PND55. However, Smith (2003) states that in order to incorporate 
the entire adolescent period, dosing should occur between PND28-PND60. As human 
adolescents are consuming caffeine from early adolescence, if not earlier, it may be 
appropriate for future research to incorporate the earlier stages of this developmental period 
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as well. Many of the neurochemical changes which occur at a young age, take place during a 
critical window of time in the pre-pubertal stages (Andersen, 2003). This information would 
also suggest that encompassing the early stages of adolescence in the dosing period could 
potentially provide more accurate information on the long-term effects caffeine may have on 
brain development.  
 
Middle and late adulthood were the age ranges tested in this study. Testing rats through all 
the stages of adulthood, for example from early adulthood through to late adulthood, or old 
age,  may also increase our understanding of the drug’s effects. As emotionality in rats may 
possibly increase with age (Bessa, et al., 2005; Imhof, et al., 1993), this could help to clarify 
some of the age-related effects seen in the results of this study.  
 
While the open-field and emergence tests are both common behavioural paradigms used to 
test for emotionality, there are other appropriate tests which may provide more data on the 
behavioural consequences of caffeine exposure.  For example, following completion of all the 
behavioural testing described in this thesis, the relative adrenal weights of a small sample of 
saline- and caffeine-treated rats were determined when they were about 10 months old. 
Higher adrenal weights have been associated with emotional reactivity (Henry & Stephens, 
1980). It was found that males’ adrenal weights were heavier after adolescent caffeine 
treatment (Anderson & Hughes, 2008). Further research into this finding should involve 
weighing the adrenal glands of a higher proportion of the subjects, and including subjects 
from all treatment groups.  
 
Millan (2003) provides an explanation of experimental models of anxiety widely used in 
rodents, which is summarised below, in Figure 1. Clearly, the two tests of anxiety used in this 
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research (the open field and emergence tests) are potentially limited in the amount and types 
of emotionality (anxiety) that they may capture. The reliability of other anxiety measures is 
not commented on in this paper, but this would need to be considered if different tests of 
anxiety were to be employed. 
 
I. “Trait”, long-term anxious states 
(A) Rodent strains displaying high or low anxiety 
(B) Inter-individual differences within a defined strain 
(C) Chronic exposure to fear-provoking stimuli 
(D) Genetic models: transgenic and knock-out mice 
II. “State”, acute anxious states 
(A) Unconditioned 
(1) Exploration (avoidance, conflict) 
(i)  Light–dark box 
(ii) Hole board (nose pokes) 
(iii) Elevated plus-maze (open arms vs. closed arms) 
(iv) Open field (central squares vs. peripheral squares) 
(v) Neophobia/emergence test (novel object) 
(2) Interaction based 
(i) Active social interaction (unfamiliar rat pairs) 
(ii) Resident intruder 
(iii) Ultrasonic vocalization (separation induced) 
(3) Acute response to aversive stimuli (environment or brain stimulation) 
(i) Freezing 
(ii) Ultrasonic vocalization 
(iii) Startle 
(iv) Autonomic-cardiovascular parameters (arterial pressure, heart 
rate, endocrine secretion) 
(4) Defensive behaviour to threatening stimuli 
(i) Fear/defence battery 
(B) Conditioned 
(1) Conflict procedures 
(i) Geller–Seifter (operant, lever-pressing for reward) 
(ii) Vogel Conflict Test 
(iii) Conditioned suppression (no punishment during test session) 
(iv) Safety-signal withdrawal (no punishment during test session) 
(v) Conditioned place aversion 
(2) Non-conflict procedures 
(i) Fear-induced freezing, startle and ultrasonic vocalizations (re-
exposure to aversive environment) 
(ii) Shock-probe (burying of aversive object) 
(3) Drug-discrimination 
(i) Anxiogenic agents 
Figure 1: Experimental models of anxiety widely used in rodents. Adapted from Millan 
(2003, p.87). 
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As adolescent caffeine consumption continues to increase, the number of adults who will 
have been exposed to caffeine during this age will also rise. If anxiety is a possible effect 
from exposure to caffeine in adolescence, this could have important clinical implications for 
the future. Anxiety is already extremely prevalent in today’s society (Beidel & Stipelman, 
2007), so broadening our knowledge base of how some of this anxiety may potentially be 
avoided earlier on in life would be beneficial, both clinically and socially. It seems clear 
through the animal literature, including this study, that while caffeine can be viewed as a 
weak teratogen (Nehlig & Debry, 1994), exposure to this drug at many stages in development 
does have lasting behavioural effects in rodents (Hughes & Beveridge, 1987, 1991; Hughes 
& Loader, 1996). Important to consider also, is that generalising animal studies to humans is 
not without its difficulties. One must consider the differing developmental pathways rats 
experience compared to humans from gestation and birth through to adulthood (Clancy, et al., 
2007). Therefore, to completely understand the clinical implications of caffeine exposure 
during adolescence, studying the effects on humans directly should be undertaken. It does 
seem clear that clinical research on caffeine exposure during adolescence is needed. 
9.0 Conclusions 
Caffeine is one of the world’s most widely used psychotropic drug (Hughes, 1996; Liguori, et 
al., 1997; Nehlig, et al., 1992; Weinberg & Bealer, 2001; Zahn & Rapoport, 1987), yet its 
methods of action and long-term effects are not understood fully. Children and adolescents 
are consuming caffeine regularly (Knight, et al., 2004; Reissig, et al., 2009; Skinner, et al., 
2000). However their brains are undergoing considerable change during these vulnerable 
years (Andersen, 2003). There has been little research investigating the effects caffeine may 
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have on the developing adolescent brain. This study sought to investigate some of the long-
term effects caffeine may have, when administered during the adolescent period.  
 
The caffeine exposure may have led to functional changes in the brain, in particular in  
regions associated with adenosine and dopamine activity. A limitation of the present study 
was that analyses of neurochemical changes in the brain was not performed. Therefore there 
is no conclusive evidence of exactly how caffeine had exerted its effects in the brain. 
 
What this research shows, despite its limitations, is that further research into adolescent 
caffeine use and its effects is warranted, and its clinical implications studied. This study 
found that rats exposed to caffeine during adolescence demonstrated some increases in 
emotionality. It is possible then, that people exposed to caffeine as adolescents, may show 
increased anxiety later in life. 
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Cage No. Rat        
Date MALES  Defaecation Urination Rearing 
(corners) 
Rearing 
(outer) 
Rearing 
(inner) 
Freezing Locomotion 
score 
04.10.06 High 1 Red #1 6 1 9 8 1 3 28 
04.10.06  Blue #2 6 2 15 21 4 6 56 
04.10.06  Green #3 6 0 19 14 7 3 59 
04.10.06 High 2 Red #4 0 0 22 16 4 4 99 
04.10.06  Blue #5 1 0 20 15 7 4 86 
04.10.06  Green #6 3 0 14 12 5 7 80 
04.10.06 High 3 Red #7 0 0 22 18 8 2 63 
04.10.06  Blue #8 1 0 18 15 7 2 60 
04.10.06  Green #9 2 0 24 19 7 3 77 
02.10.06 Control 4  Red #1 0 2 24 13 4 1 57 
02.10.06  Blue #2 2 0 15 5 2 1 65 
02.10.06  Green #3 0 1 6 8 2 2 41 
02.10.06 Control 5 Red #4 1 0 33 14 3 0 70 
02.10.06  Blue #5 1 0 11 15 7 1 93 
02.10.06  Green #6 4 0 15 7 10 0 66 
02.10.06 Control 6 Red #7 2 1 14 13 2 1 63 
02.10.06  Blue #8 0 2 18 10 3 0 75 
02.10.06  Green#9 2 1 21 17 4 0 97 
03.10.06 Low 7 Red #1 0 1 21 15 3 0 84 
03.10.06  Blue #2 0 0 14 17 0 0 71 
03.10.06  Green #3 0 1 19 10 1 0 92 
03.10.06 Low 8 Red #4 0 1 21 15 0 1 54 
03.10.06  Blue #5 2 1 12 13 7 2 77 
03.10.06  Green #6 7 0 17 13 2 2 61 
03.10.06 Low 9 Red #7 0 0 13 14 1 1 48 
03.10.06  Blue #8 0 1 23 9 1 0 52 
03.10.06  Green #9 0 2 17 20 4 0 91 
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Date 
 
FEMALES 
 
Defaecation 
 
Urination 
 
Rearing 
(corners) 
 
Rearing 
(outer) 
 
Rearing 
(inner) 
 
Freezing 
 
Locomotion 
score 
04.10.06 High 10 Red #10 0 0 15 15 0 3 70 
04.10.06  Blue #11 0 0 33 17 8 1 94 
04.10.06  Green #12 7 0 23 9 2 4 91 
04.10.06 High 11 Red #13 1 0 18 20 1 1 113 
04.10.06  Blue #14 0 1 21 9 1 4 82 
04.10.06  Green #15 0 0 23 16 2 3 97 
04.10.06 High 12 Red #16 4 0 14 12 0 3 108 
04.10.06  Blue #17 0 0 28 10 5 2 77 
04.10.06  Green #18 0 0 26 16 3 2 108 
02.10.06 Control 13 Red #10 0 0 22 15 1 3 86 
02.10.06  Blue #11 0 0 17 13 5 0 106 
02.10.06  Green #12 1 0 14 17 0 0 84 
02.10.06 Control 14 Red #13 0 0 14 12 3 0 74 
02.10.06  Blue #14 0 0 23 15 2 2 90 
02.10.06  Green #15 0 0 24 19 1 0 121 
02.10.06 Control 15 Red #16 0 2 18 14 1 0 87 
02.10.06  Blue #17 0 0 20 19 0 0 93 
02.10.06  Green #18 0 0 19 23 0 0 93 
03.10.06 Low 16 Red #10 0 0 23 11 0 1 77 
03.10.06  Blue #11 0 0 23 10 2 1 96 
03.10.06  Green #12 1 0 27 14 4 1 108 
03.10.06 Low 17 Red #13 0 0 15 6 0 3 39 
03.10.06  Blue #14 3 0 27 16 2 4 93 
03.10.06  Green #15 0 0 19 18 1 6 79 
03.10.06 Low 18 Red #16 0 0 18 15 2 1 80 
03.10.06  Blue #17 0 0 19 9 6 2 103 
03.10.06  Green #18 0 0 16 15 0 2 68 
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Emergence Test Raw Data 
Testing period 1. Day 1. 
 Cage No, Rat    
Date MALES  Time to 
emerge (s)  
No. Head 
pokes 
Defaecation 
(Start Box) 
04.10.06 High 1 Red #1 300.00 14 0 
04.10.06  Blue #2 36.97 6 0 
04.10.06  Green #3 14.69 1 0 
04.10.06 High 2 Red #4 12.40 0 0 
04.10.06  Blue #5 4.31 0 0 
04.10.06  Green #6 5.63 1 0 
04.10.06 High 3 Red #7 13.66 0 0 
04.10.06  Blue #8 36.66 3 0 
04.10.06  Green #9 21.34 3 2 
02.10.06 Control 4  Red #1 10.90 1 0 
02.10.06  Blue #2 300.00 9 0 
02.10.06  Green #3 27.10 2 1 
02.10.06 Control 5 Red #4 15.30 1 0 
02.10.06  Blue #5 14.70 0 0 
02.10.06  Green #6 22.00 1 0 
02.10.06 Control 6 Red #7 56.90 5 0 
02.10.06  Blue #8 13.30 1 0 
02.10.06  Green#9 13.90 1 0 
03.10.06 Low 7 Red #1 300.00 15 1 
03.10.06  Blue #2 15.09 1 0 
03.10.06  Green #3 33.07 5 0 
03.10.06 Low 8 Red #4 15.41 1 0 
03.10.06  Blue #5 82.56 5 0 
03.10.06  Green #6 61.41 5 0 
03.10.06 Low 9 Red #7 35.60 1 0 
03.10.06  Blue #8 300.00 14 0 
03.10.06  Green #9 34.09 2 0 
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Date FEMALES Time to 
Emerge (s) 
No. Head 
Pokes 
Defaecation 
(Start Box) 
04.10.06 High 10 Red #10 23.25 2 0 
04.10.06  Blue #11 22.34 3 0 
04.10.06  Green #12 43.81 3 0 
04.10.06 High 11 Red #13 52.12 5 0 
04.10.06  Blue #14 33.19 3 0 
04.10.06  Green #15 39.84 3 0 
04.10.06 High 12 Red #16 8.18 2 0 
04.10.06  Blue #17 21.25 1 0 
04.10.06  Green #18 107.81 5 0 
02.10.06 Control 13 Red #10 12.50 0 0 
02.10.06  Blue #11 15.30 1 0 
02.10.06  Green #12 21.20 1 0 
02.10.06 Control 14 Red #13 53.60 3 0 
02.10.06  Blue #14 76.80 6 0 
02.10.06  Green #15 15.80 0 0 
02.10.06 Control 15 Red #16 300.00 8 0 
02.10.06  Blue #17 123.50 5 1 
02.10.06  Green #18 31.60 2 0 
03.10.06 Low 16 Red #10 182.84 15 0 
03.10.06  Blue #11 75.84 5 0 
03.10.06  Green #12 13.97 1 1 
03.10.06 Low 17 Red #13 45.25 4 0 
03.10.06  Blue #14 55.66 6 2 
03.10.06  Green #15 26.44 2 0 
03.10.06 Low 18 Red #16 22.78 2 0 
03.10.06  Blue #17 90.53 5 0 
03.10.06  Green #18 31.53 2 0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Emergence Test Raw Data 
Testing period 1. Day 1. 
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 Cage No. Rat        
Date MALES  Defaecation Urination Rearing 
(corners) 
Rearing 
(outer) 
Rearing 
(inner) 
Freezing Locomotion 
score 
08.10.06 High 1 Red #1 0 0 7 1 0 1 19 
08.10.06  Blue #2 4 1 6 7 1 4 35 
08.10.06  Green #3 8 3 9 4 1 2 42 
08.10.06 High 2 Red #4 0 0 25 19 0 5 110 
08.10.06  Blue #5 7 1 16 14 0 3 69 
08.10.06  Green #6 7 1 13 9 0 5 73 
08.10.06 High 3 Red #7 6 0 31 11 0 2 92 
08.10.06  Blue #8 0 0 11 7 0 3 41 
08.10.06  Green #9 0 1 17 9 0 1 57 
06.10.06 Control 4  Red #1 3 1 23 18 0 0 70 
06.10.06  Blue #2 0 1 12 11 0 3 59 
06.10.06  Green #3 0 1 22 12 4 2 77 
06.10.06 Control 5 Red #4 0 0 24 19 1 2 86 
06.10.06  Blue #5 1 0 14 7 0 3 57 
06.10.06  Green #6 0 0 15 12 0 4 45 
06.10.06 Control 6 Red #7 1 0 6 6 0 2 27 
06.10.06  Blue #8 0 0 20 9 0 2 78 
06.10.06  Green#9 0 0 18 11 0 0 80 
07.10.06 Low 7 Red #1 0 1 7 0 0 0 11 
07.10.06  Blue #2 0 0 14 6 0 1 47 
07.10.06  Green #3 0 0 11 9 0 2 39 
07.10.06 Low 8 Red #4 0 0 13 7 0 2 47 
07.10.06  Blue #5 6 1 11 9 1 1 54 
07.10.06  Green #6 8 0 24 22 3 2 71 
07.10.06 Low 9 Red #7 0 0 8 18 0 2 50 
07.10.06  Blue #8 0 0 2 6 0 0 10 
07.10.06  Green #9 0 0 13 4 0 0 35 
 
65
 
  
66 
 
O
p
en
 Field
 R
a
w
 D
ata
 
T
esting
 p
eriod
 1
.
 D
ay
 2
.
 
 
Date FEMALES Defaecation Urination Rearing 
(corners) 
Rearing 
(outer) 
Rearing 
(inner) 
Freezing Locomotion 
score 
08.10.06 High 10 Red #10 2 0 17 11 3 4 91 
08.10.06  Blue #11 2 0 14 16 3 0 95 
08.10.06  Green #12 5 1 20 18 1 1 101 
08.10.06 High 11 Red #13 0 0 16 10 2 0 108 
08.10.06  Blue #14 2 2 24 9 0 0 115 
08.10.06  Green #15 1 1 15 3 0 1 49 
08.10.06 High 12 Red #16 4 2 10 9 7 3 98 
08.10.06  Blue #17 1 0 13 9 4 1 77 
08.10.06  Green #18 0 0 12 15 1 2 104 
06.10.06 Control 13 Red #10 0 0 18 12 0 2 40 
06.10.06  Blue #11 0 0 15 13 2 2 81 
06.10.06  Green #12 0 0 22 8 0 0 69 
06.10.06 Control 14 Red #13 0 0 14 17 1 0 82 
06.10.06  Blue #14 0 0 12 10 2 2 88 
06.10.06  Green #15 0 1 1 1 0 0 29 
06.10.06 Control 15 Red #16 1 0 17 3 0 0 62 
06.10.06  Blue #17 0 0 17 14 0 0 78 
06.10.06  Green #18 0 1 12 16 0 3 73 
07.10.06 Low 16 Red #10 0 0 15 7 0 0 81 
07.10.06  Blue #11 0 0 2 0 0 2 39 
07.10.06  Green #12 0 0 4 0 0 1 14 
07.10.06 Low 17 Red #13 0 0 7 3 0 1 35 
07.10.06  Blue #14 5 1 25 13 5 0 109 
07.10.06  Green #15 0 0 16 10 1 1 84 
07.10.06 Low 18 Red #16 0 0 5 0 0 1 29 
07.10.06  Blue #17 0 0 20 18 4 3 108 
07.10.06  Green #18 0 0 6 6 0 1 43 
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 Cage No. Rat  
Date MALES  Time to 
emerge (s) 
No. Head 
pokes 
Defaecation 
(Start Box) 
08.10.06 High 1 Red #1 300.00 6 0 
08.10.06  Blue #2 12.63 2 0 
08.10.06  Green #3 171.03 13 0 
08.10.06 High 2 Red #4 6.91 1 0 
08.10.06  Blue #5 17.22 2 0 
08.10.06  Green #6 12.19 1 0 
08.10.06 High 3 Red #7 22.88 3 0 
08.10.06  Blue #8 30.09 4 0 
08.10.06  Green #9 10.22 1 0 
06.10.06 Control 4  Red #1 37.68 6 0 
06.10.06  Blue #2 300.00 7 2 
06.10.06  Green #3 5.78 1 0 
06.10.06 Control 5 Red #4 13.09 1 0 
06.10.06  Blue #5 300.00 15 0 
06.10.06  Green #6 58.22 2 0 
06.10.06 Control 6 Red #7 216.37 6 0 
06.10.06  Blue #8 10.00 1 0 
06.10.06  Green#9 6.31 1 0 
07.10.06 Low 7 Red #1 300.00 6 0 
07.10.06  Blue #2 151.62 8 0 
07.10.06  Green #3 86.78 6 0 
07.10.06 Low 8 Red #4 69.37 5 0 
07.10.06  Blue #5 65.50 6 0 
07.10.06  Green #6 300.00 17 0 
07.10.06 Low 9 Red #7 300.00 10 0 
07.10.06  Blue #8 300.00 7 0 
07.10.06  Green #9 160.06 10 0 
Emergence Test Raw Data 
Testing period 1. Day 2. 
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Date FEMALES Time to 
Emerge (s) 
No. Head 
Pokes 
Defaecation 
(Start Box) 
08.10.06 High 10 Red #10 86.59 5 0 
08.10.06  Blue #11 237.72 9 0 
08.10.06  Green #12 16.75 3 0 
08.10.06 High 11 Red #13 82.79 3 0 
08.10.06  Blue #14 14.85 2 0 
08.10.06  Green #15 30.94 2 0 
08.10.06 High 12 Red #16 20.06 2 0 
08.10.06  Blue #17 24.81 3 0 
08.10.06  Green #18 15.28 1 0 
06.10.06 Control 13 Red #10 16.78 2 0 
06.10.06  Blue #11 18.78 1 0 
06.10.06  Green #12 57.35 6 0 
06.10.06 Control 14 Red #13 93.85 2 0 
06.10.06  Blue #14 55.44 1 0 
06.10.06  Green #15 120.19 9 0 
06.10.06 Control 15 Red #16 113.66 4 1 
06.10.06  Blue #17 71.47 6 0 
06.10.06  Green #18 42.18 4 0 
07.10.06 Low 16 Red #10 300.00 11 0 
07.10.06  Blue #11 10.62 1 0 
07.10.06  Green #12 300.00 14 1 
07.10.06 Low 17 Red #13 191.81 4 0 
07.10.06  Blue #14 112.18 10 0 
07.10.06  Green #15 79.97 8 0 
07.10.06 Low 18 Red #16 300.00 13 0 
07.10.06  Blue #17 97.09 7 0 
07.10.06  Green #18 300.00 10 0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Emergence Test Raw Data 
Testing Period 1. Day 2. 
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 Cage No. Rat        
Date MALES  Defaecation Urination Rearing 
(corners) 
Rearing 
(outer) 
Rearing 
(inner) 
Freezing Locomotion score 
12.10.06 High 1 Red #1 0 1 9 6 0 2 27 
12.10.06  Blue #2 5 2 17 17 0 5 66 
12.10.06  Green #3 2 1 19 10 2 4 55 
12.10.06 High 2 Red #4 0 0 14 9 0 3 66 
12.10.06  Blue #5 0 0 20 10 3 6 80 
12.10.06  Green #6 8 0 8 16 0 6 67 
12.10.06 High 3 Red #7 0 1 30 14 1 2 75 
12.10.06  Blue #8 0 0 12 15 0 0 48 
12.10.06  Green #9 0 0 15 15 0 0 41 
10.10.06 Control 4  Red #1 4 1 20 29 1 1 88 
10.10.06  Green #3 0 0 16 12 0 2 55 
10.10.06 Control 5 Red #4 0 0 24 18 1 1 79 
10.10.06  Blue #5 0 0 17 26 0 3 78 
10.10.06  Green #6 0 0 14 11 1 1 46 
10.10.06 Control 6 Red #7 0 0 5 1 0 3 16 
10.10.06  Blue #8 0 0 17 18 0 2 74 
10.10.06  Green#9 6 0 19 8 1 1 71 
11.10.06 Low 7 Red #1 0 0 2 1 0 1 16 
11.10.06  Blue #2 0 0 6 5 1 3 42 
11.10.06  Green #3 0 0 21 8 1 2 66 
11.10.06 Low 8 Red #4 0 0 12 4 0 2 42 
11.10.06  Blue #5 3 1 8 4 0 2 36 
11.10.06  Green #6 4 0 17 23 2 1 73 
11.10.06 Low 9 Red #7 5 1 11 12 0 2 47 
11.10.06  Blue #8 8 1 17 2 3 1 36 
11.10.06  Green #9 0 2 12 5 0 3 41 
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Date FEMALES Defaecation Urination Rearing 
(corners) 
Rearing 
(outer) 
Rearing 
(inner) 
Freezing Locomotion score 
12.10.06 High 10 Red #10 0 0 20 18 2 1 132 
12.10.06  Blue #11 0 0 18 9 1 6 90 
12.10.06  Green #12 7 1 14 18 3 3 90 
12.10.06 High 11 Red #13 0 0 14 18 3 3 125 
12.10.06  Blue #14 0 1 23 11 0 4 113 
12.10.06  Green #15 0 0 22 10 0 0 77 
12.10.06 High 12 Red #16 4 1 13 15 3 4 92 
12.10.06  Blue #17 2 0 17 12 4 0 81 
12.10.06  Green #18 0 1 23 14 6 1 110 
10.10.06 Control13 Red #10 0 0 21 26 3 0 119 
10.10.06  Blue #11 0 0 22 28 3 0 99 
10.10.06  Green #12 0 1 20 17 2 2 113 
10.10.06 Control 14 Red #13 0 0 10 7 0 5 59 
10.10.06  Blue #14 0 0 18 16 4 2 95 
10.10.06  Green #15 0 0 15 8 0 0 68 
10.10.06 Control 15 Red #16 0 0 11 9 0 1 60 
10.10.06  Blue #17 0 0 24 16 0 1 110 
10.10.06  Green #18 0 0 23 9 0 0 56 
11.10.06 Low 16 Red #10 0 1 18 17 0 4 117 
11.10.06  Blue #11 0 0 16 7 0 2 90 
11.10.06  Green #12 2 0 12 1 1 2 34 
11.10.06 Low 17 Red #13 0 0 19 10 0 3 72 
11.10.06  Blue #14 6 1 29 25 3 0 117 
11.10.06  Green #15 0 0 17 15 2 4 97 
11.10.06 L18 Red #16 0 0 13 15 0 0 75 
11.10.06  Blue #17 3 2 18 20 2 4 109 
11.10.06  Green #18 0 0 18 18 5 2 95 
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 Cage No. Rat  
Date MALES  Time to 
emerge (s)  
No. Head 
pokes 
Defaecation 
(Start Box) 
12.10.06 High 1 Red #1 300.00 1 0 
12.10.06  Blue #2 36.28 3 0 
12.10.06  Green #3 300.00 11 0 
12.10.06 High 2 Red #4 7.62 1 0 
12.10.06  Blue #5 76.81 4 0 
12.10.06  Green #6 62.88 5 0 
12.10.06 High 3 Red #7 80.56 5 0 
12.10.06  Blue #8 59.85 4 0 
12.10.06  Green #9 13.78 2 0 
10.10.06 Control 4  Red #1 14.38 1 0 
10.10.06  Blue #2 300.00 6 0 
10.10.06  Green #3 117.44 12 0 
10.10.06 Control 5 Red #4 6.00 1 0 
10.10.06  Blue #5 300.00 4 0 
10.10.06  Green #6 300.00 11 0 
10.10.06 Control 6 Red #7 300.00 5 0 
10.10.06  Blue #8 6.35 1 0 
10.10.06  Green#9 4.25 1 0 
11.10.06 Low 7 Red #1 300.00 7 0 
11.10.06  Blue #2 47.90 2 0 
11.10.06  Green #3 158.53 12 0 
11.10.06 Low 8 Red #4 69.16 2 0 
11.10.06  Blue #5 100.41 5 0 
11.10.06  Green #6 131.69 8 0 
11.10.06 Low 9 Red #7 247.03 6 0 
11.10.06  Blue #8 300.00 7 0 
11.10.06  Green #9 55.97 6 0 
Emergence Test Raw Data. 
Testing period 1. Day 3. 
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Date FEMALES Time to 
Emerge (s) 
No. Head 
Pokes 
Defaecation 
(Start Box) 
12.10.06 High 10 Red #10 9.40 1 0 
12.10.06  Blue #11 39.94 1 0 
12.10.06  Green #12 89.62 4 0 
12.10.06 High 11 Red #13 17.82 1 0 
12.10.06  Blue #14 5.72 1 0 
12.10.06  Green #15 72.82 5 0 
12.10.06 High 12 Red #16 47.97 3 0 
12.10.06  Blue #17 19.35 1 0 
12.10.06  Green #18 17.35 1 0 
10.10.06 Control 13 Red #10 13.06 2 0 
10.10.06  Blue #11 7.97 1 0 
10.10.06  Green #12 9.78 1 0 
10.10.06 Control 14 Red #13 97.50 7 0 
10.10.06  Blue #14 12.00 1 0 
10.10.06  Green #15 300.00 9 0 
10.10.06 Control 15 Red #16 242.04 7 0 
10.10.06  Blue #17 8.59 1 0 
10.10.06  Green #18 85.94 5 0 
11.10.06 Low 16 Red #10 300.00 13 3 
11.10.06  Blue #11 26.12 2 0 
11.10.06  Green #12 197.44 1 0 
11.10.06 Low 17 Red #13 93.22 4 0 
11.10.06  Blue #14 10.81 1 0 
11.10.06  Green #15 47.75 6 0 
11.10.06 Low 18 Red #16 61.88 5 0 
11.10.06  Blue #17 8.85 1 0 
11.10.06  Green #18 179.47 9 0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Emergence Test Raw Data. 
Testing period 1. Day 3. 
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 Cage No. Rat        
Date MALES  Defaecation Urination Rearing 
(corners) 
Rearing 
(outer) 
Rearing 
(inner) 
Freezing Locomotion 
score 
23.11.06 High 1 Red #1 0 1 9 15 2 3 13 
23.11.06  Blue #2 0 2 19 24 0 0 65 
23.11.06  Green #3 3 1 8 14 7 2 46 
23.11.06 High 2 Red #4 0 0 28 8 1 2 59 
23.11.06  Blue #5 3 0 16 14 2 0 85 
23.11.06  Green #6 7 2 15 14 2 1 59 
23.11.06 High 3 Red #7 3 2 17 20 3 1 58 
23.11.06  Blue #8 0 0 17 12 0 2 39 
23.11.06  Green #9 0 0 16 1 0 1 29 
17.11.06 Control 4  Red #1 0 1 7 13 0 2 46 
17.11.06  Blue #2 0 0 8 4 0 3 30 
17.11.06 Control 5 Red #3 0 1 19 20 4 0 61 
17.11.06  Blue #4 6 2 15 21 0 1 68 
17.11.06  Green #5 0 0 9 11 6 1 45 
17.11.06 Control 6 Red #6 0 2 7 0 0 0 10 
17.11.06  Blue #7 0 0 14 10 3 0 49 
17.11.06  Green#9 2 0 14 12 1 2 71 
22.11.06 Low 7 Red #1 0 4 5 2 0 1 23 
22.11.06  Blue #2 0 0 16 9 0 0 56 
22.11.06  Green #3 0 0 12 3 0 1 25 
22.11.06 Low 8 Red #4 0 0 19 4 0 1 63 
22.11.06  Blue #5 4 1 9 15 0 0 49 
22.11.06  Green #6 6 0 18 22 2 1 55 
22.11.06 Low 9 Red #7 0 0 19 19 4 0 72 
22.11.06  Blue #8 2 2 20 8 0 0 46 
22.11.06  Green #9 0 0 29 17 0 0 60 
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Date 
 
FEMALES 
 
Defaecation 
 
Urination 
 
Rearing 
(corners) 
 
Rearing 
(outer) 
 
Rearing 
(inner) 
 
Freezing 
 
Locomotion 
score 
23.11.06 High 10 Red #10 4 0 21 26 1 1 81 
23.11.06  Blue #11 5 0 17 18 3 1 74 
23.11.06  Green #12 4 2 13 19 3 0 84 
23.11.06 High 11 Red #13 0 1 21 20 4 2 121 
23.11.06  Blue #14 0 0 28 14 4 2 123 
23.11.06  Green #15 2 0 26 15 1 0 79 
23.11.06 High 12 Red #16 3 2 14 20 4 3 99 
23.11.06  Blue #17 5 1 23 12 1 0 67 
23.11.06  Green #18 0 0 28 26 2 1 102 
17.11.06 Control 13 Red #10 0 0 23 39 3 0 103 
17.11.06  Blue #11 0 2 22 21 0 0 85 
17.11.06  Green #12 2 0 22 30 9 0 103 
17.11.06 Control 14 Red #13 0 0 26 29 2 0 88 
17.11.06  Blue #14 0 0 15 14 1 0 73 
17.11.06  Green #15 0 0 7 7 1 1 49 
17.11.06 Control 15 Red #16 5 1 17 26 7 0 85 
17.11.06  Blue #17 0 0 12 15 5 2 87 
17.11.06  Green #18 0 0 22 22 5 0 79 
22.11.06 Low 16 Red #10 0 0 25 30 0 1 97 
22.11.06  Blue #11 3 1 21 19 1 2 91 
22.11.06  Green #12 1 0 12 7 3 1 28 
22.11.06 Low 17 Red #13 0 0 16 3 0 2 45 
22.11.06  Blue #14 0 0 14 5 1 1 93 
22.11.06  Green #15 0 1 17 12 2 0 77 
22.11.06 Low 18 Red #16 0 3 5 5 1 1 55 
22.11.06  Blue #17 4 0 8 8 3 0 66 
22.11.06  Green #18 0 0 16 7 0 0 50 
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 Cage No. Rat  
Date MALES  Time to 
emerge (s)  
No. Head 
pokes 
Defaecation 
(Start Box) 
23.11.06 High 1 Red #1 300.00 4 5 
23.11.06  Blue #2 17.00 2 0 
23.11.06  Green #3 300.00 8 2 
23.11.06 High 2 Red #4 43.15 3 0 
23.11.06  Blue #5 35.63 5 0 
23.11.06  Green #6 40.47 5 0 
23.11.06 High 3 Red #7 50.97 5 0 
23.11.06  Blue #8 14.28 2 0 
23.11.06  Green #9 122.53 10 0 
17.11.06 Control 4  Red #1 160.60 5 0 
17.11.06  Blue #2 300.00 4 0 
17.11.06 Control 5 Red #3 110.50 5 0 
17.11.06  Blue #4 300.00 9 0 
17.11.06  Green #5 300.00 6 0 
17.11.06 Control 6 Red #6 300.00 6 0 
17.11.06  Blue #7 17.93 1 0 
17.11.06  Green#9 80.78 6 0 
22.11.06 Low 7 Red #1 300.00 0 0 
22.11.06  Blue #2 300.00 6 0 
22.11.06  Green #3 300.00 9 0 
22.11.06 Low 8 Red #4 90.34 4 0 
22.11.06  Blue #5 300.00 8 2 
22.11.06  Green #6 130.53 8 2 
22.11.06 Low 9 Red #7 300.00 6 0 
22.11.06  Blue #8 300.00 1 0 
22.11.06  Green #9 300.00 9 0 
Emergence Test Raw Data. 
Testing period 2. Day 1. 
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Date FEMALES Time to 
Emerge (s) 
No. Head 
Pokes 
Defaecation 
(Start Box) 
23.11.06 High 10 Red #10 95.16 9 0 
23.11.06  Blue #11 40.22 4 0 
23.11.06  Green #12 30.25 3 0 
23.11.06 High 11 Red #13 179.56 4 0 
23.11.06  Blue #14 4.25 0 0 
23.11.06  Green #15 45.53 1 0 
23.11.06 High 12 Red #16 169.81 9 0 
23.11.06  Blue #17 22.28 2 0 
23.11.06  Green #18 8.81 1 0 
17.11.06 Control 13 Red #10 13.69 3 0 
17.11.06  Blue #11 57.66 2 0 
17.11.06  Green #12 126.84 6 0 
17.11.06 Control 14 Red #13 300.00 6 0 
17.11.06  Blue #14 151.13 4 0 
17.11.06  Green #15 248.82 7 1 
17.11.06 Control 15 Red #16 300.00 5 0 
17.11.06  Blue #17 300.00 12 0 
17.11.06  Green #18 300.00 16 0 
22.11.06 Low 16 Red #10 300.00 11 2 
22.11.06  Blue #11 20.97 3 0 
22.11.06  Green #12 300.00 5 3 
22.11.06 Low 17 Red #13 300.00 11 0 
22.11.06  Blue #14 36.43 4 0 
22.11.06  Green #15 62.93 7 0 
22.11.06 Low 18 Red #16 300.00 7 0 
22.11.06  Blue #17 300.00 14 0 
22.11.06  Green #18 300.00 13 0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Emergence Test Raw Data. 
Testing period 2. Day 1. 
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 Cage No. Rat        
Date MALES  Defaecation Urination Rearing 
(corners) 
Rearing 
(outer) 
Rearing 
(inner) 
Freezing Locomotion 
score 
28.11.06 High 1 Red #1 0 0 7 3 1 0 18 
28.11.06  Blue #2 0 0 23 19 4 2 86 
28.11.06  Green #3 0 0 11 20 11 0 59 
28.11.06 High 2 Red #4 0 0 21 14 0 0 73 
28.11.06  Blue #5 0 1 20 5 1 1 73 
28.11.06  Green #6 6 2 16 18 2 3 71 
28.11.06 High 3 Red #7 3 0 29 24 7 1 81 
28.11.06  Blue #8 0 0 10 11 2 1 54 
28.11.06  Green #9 0 0 17 14 0 0 36 
25.11.06 Control 4  Red #1 2 1 17 13 0 0 38 
25.11.06  Blue #2 0 1 8 3 1 1 37 
25.11.06 Control 5 Red #3 0 0 18 12 0 3 57 
25.11.06  Blue #4 0 3 21 24 7 0 98 
25.11.06  Green #5 0 0 11 17 0 1 44 
25.11.06 Control 6 Red #6 4 0 7 1 0 1 14 
25.11.06  Blue #7 0 0 19 15 0 0 56 
25.11.06  Green#8 0 0 17 11 0 2 80 
26.11.06 Low 7 Red #1 0 3 5 0 0 1 26 
26.11.06  Blue #2 0 0 18 14 0 1 70 
26.11.06  Green #3 0 0 10 8 0 2 47 
26.11.06 Low 8 Red #4 0 0 15 9 3 3 60 
26.11.06  Blue #5 3 0 9 9 0 2 43 
26.11.06  Green #6 4 1 11 25 0 4 48 
26.11.06 Low 9 Red #7 0 0 16 16 1 1 49 
26.11.06  Blue #8 0 0 14 5 1 0 22 
26.11.06  Green #9 0 0 22 12 3 1 57 
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Date FEMALES Defaecation Urination Rearing 
(corners) 
Rearing 
(outer) 
Rearing 
(inner) 
Freezing Locomotion 
score 
28.11.06 High 10 Red #10 0 0 18 21 5 1 118 
28.11.06  Blue #11 0 0 21 23 0 2 98 
28.11.06  Green #12 5 2 15 12 0 1 73 
28.11.06 High 11 Red #13 0 0 23 18 5 2 100 
28.11.06  Blue #14 0 1 29 18 1 1 125 
28.11.06  Green #15 0 0 20 24 6 0 96 
28.11.06 High 12 Red #16 7 3 11 6 1 0 60 
28.11.06  Blue #17 0 0 17 8 1 0 60 
28.11.06  Green #18 0 0 22 20 3 0 104 
25.11.06 Control 13 Red #10 0 0 24 23 3 0 99 
25.11.06  Blue #11 0 0 24 17 1 0 91 
25.11.06  Green #12 0 2 16 23 2 1 92 
25.11.06 Control 14 Red #13 0 0 15 18 2 1 59 
25.11.06  Blue #14 0 0 16 17 4 1 87 
25.11.06  Green #15 0 0 14 8 1 0 67 
25.11.06 Control 15 Red #16 0 0 17 19 0 1 87 
25.11.06  Blue #17 0 0 16 16 0 1 107 
25.11.06  Green #18 0 0 17 14 1 1 76 
26.11.06 Low 16 Red #10 0 0 17 23 2 4 81 
26.11.06  Blue #11 0 0 13 8 2 3 75 
26.11.06  Green #12 0 0 4 1 1 2 29 
26.11.06 Low 17 Red #13 0 0 16 11 3 0 64 
26.11.06  Blue #14 0 0 13 10 2 5 84 
26.11.06  Green #15 0 0 28 27 2 1 87 
26.11.06 Low 18 Red #16 0 0 12 13 2 2 65 
26.11.06  Blue #17 6 0 12 13 2 1 73 
26.11.06  Green #18 0 0 11 9 1 0 70 
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 Cage No. Rat  
Date MALES  Time to 
emerge (s)  
No. Head 
pokes 
Defaecation 
(Start Box) 
28.11.06 High 1 Red #1 300.00 4 0 
28.11.06  Blue #2 9.44 2 0 
28.11.06  Green #3 300.00 9 1 
28.11.06 High 2 Red #4 61.72 3 0 
28.11.06  Blue #5 6.53 0 0 
28.11.06  Green #6 24.19 1 0 
28.11.06 High 3 Red #7 28.84 1 0 
28.11.06  Blue #8 11.06 0 0 
28.11.06  Green #9 26.94 2 0 
25.11.06 Control 4  Red #1 35.63 3 0 
25.11.06  Blue #2 300.00 5 0 
25.11.06 Control 5 Red #3 29.78 3 0 
25.11.06  Blue #4 60.60 6 0 
25.11.06  Green #5 189.21 17 0 
25.11.06 Control 6 Red #6 118.19 7 0 
25.11.06  Blue #7 83.59 6 0 
25.11.06  Green#8 70.22 5 0 
26.11.06 Low 7 Red #1 300.00 1 0 
26.11.06  Blue #2 15.84 1 0 
26.11.06  Green #3 64.50 5 0 
26.11.06 Low 8 Red #4 27.44 2 0 
26.11.06  Blue #5 300.00 15 0 
26.11.06  Green #6 52.59 5 0 
26.11.06 Low 9 Red #7 26.13 2 0 
26.11.06  Blue #8 40.10 4 0 
26.11.06  Green #9 300.00 19 0 
Emergence Test Raw Data. 
Testing period 2. Day 2. 
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Date FEMALES Time to 
Emerge (s) 
No. Head 
Pokes 
Defaecation 
(Start Box) 
28.11.06 High 10 Red #10 35.34 5 0 
28.11.06  Blue #11 12.59 1 0 
28.11.06  Green #12 52.19 1 0 
28.11.06 High 11 Red #13 102.31 5 0 
28.11.06  Blue #14 77.03 5 0 
28.11.06  Green #15 300.00 13 0 
28.11.06 High 12 Red #16 77.19 3 0 
28.11.06  Blue #17 142.72 9 0 
28.11.06  Green #18 6.41 1 0 
25.11.06 Control 13 Red #10 5.69 0 0 
25.11.06  Blue #11 26.38 1 0 
25.11.06  Green #12 37.75 5 0 
25.11.06 Control 14 Red #13 57.72 2 0 
25.11.06  Blue #14 129.78 7 0 
25.11.06  Green #15 83.03 5 0 
25.11.06 Control 15 Red #16 248.25 4 0 
25.11.06  Blue #17 16.03 2 0 
25.11.06  Green #18 300.00 9 0 
26.11.06 Low 16 Red #10 300.00 17 0 
26.11.06  Blue #11 12.59 0 0 
26.11.06  Green #12 29.69 2 0 
26.11.06 Low 17 Red #13 300.00 16 0 
26.11.06  Blue #14 58.47 4 0 
26.11.06  Green #15 38.47 5 0 
26.11.06 Low 18 Red #16 205.47 13 0 
26.11.06  Blue #17 165.66 7 0 
26.11.06  Green #18 21.53 2 0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Emergence Test Raw Data. 
Testing period 2. Day 2. 
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 Cage No. Rat        
Date MALES  Defaecation Urination Rearing 
(corners) 
Rearing 
(outer) 
Rearing 
(inner) 
Freezing Locomotion 
score 
01.12.06 High 1 Red #1 4 0 17 14 2 1 31 
01.12.06  Blue #2 0 0 25 14 4 5 77 
01.12.06  Green #3 1 0 20 22 1 2 61 
01.12.06 High 2 Red #4 0 0 33 12 0 1 107 
01.12.06  Blue #5 0 0 19 16 3 6 85 
01.12.06  Green #6 1 1 6 4 0 3 43 
01.12.06 High 3 Red #7 3 0 36 20 1 1 92 
01.12.06  Blue #8 0 0 23 18 0 0 74 
01.12.06  Green #9 0 0 19 12 0 0 49 
29.11.06 Control 4  Red #1 0 0 12 18 1 0 42 
29.11.06  Blue #2 0 2 9 4 0 1 44 
29.11.06 Control 5 Blue #4 0 0 14 27 3 0 90 
29.11.06  Green #5 0 0 15 22 2 4 55 
29.11.06 Control 6 Red #6 0 0 23 12 2 1 57 
29.11.06  Blue #7 0 0 24 9 1 2 64 
29.11.06  Green#9 0 0 15 6 1 2 52 
30.11.06 Low 7 Red #1 0 2 9 2 0 3 23 
30.11.06  Blue #2 0 0 18 12 2 3 78 
30.11.06  Green #3 0 1 10 20 4 3 74 
30.11.06 Low 8 Red #4 0 0 18 9 3 1 66 
30.11.06  Blue #5 2 1 14 15 2 1 66 
30.11.06  Green #6 7 2 19 25 7 3 75 
30.11.06 Low 9 Red #7 0 0 14 13 4 3 66 
30.11.06  Blue #8 0 1 25 14 2 0 52 
30.11.06  Green #9 0 0 18 14 2 1 67 
O
p
en
 Field
 R
a
w
 D
ata
.
 
T
esting
 p
eriod
 2
.
 D
ay
 3
.
 
81
 
 
  
82 
 
 
 
Date 
 
FEMALES 
 
Defaecation 
 
Urination 
 
Rearing 
(corners) 
 
Rearing 
(outer) 
 
Rearing 
(inner) 
 
Freezing 
 
Locomotion 
score 
01.12.06 High 10 Red #10 0 0 21 31 6 3 115 
01.12.06  Blue #11 0 0 27 27 8 4 135 
01.12.06  Green #12 7 2 18 20 6 6 129 
01.12.06 High 11 Red #13 0 0 18 11 2 1 102 
01.12.06  Blue #14 0 2 24 18 1 0 128 
01.12.06  Green #15 0 0 21 20 7 1 119 
01.12.06 High 12 Red #16 6 2 14 13 10 5 95 
01.12.06  Blue #17 0 0 17 18 0 0 78 
01.12.06  Green #18 0 0 20 12 7 4 108 
29.11.06 Control 13 Red #10 0 0 25 28 5 0 119 
29.11.06  Blue #11 0 2 28 16 3 2 127 
29.11.06  Green #12 0 0 26 21 5 0 134 
29.11.06 Control 14 Red #13 0 0 17 26 8 1 90 
29.11.06  Blue #14 0 0 24 25 3 0 109 
29.11.06  Green #15 0 0 20 11 1 0 77 
29.11.06 Control 15 Red #16 0 0 23 15 0 0 86 
29.11.06  Blue #17 0 0 16 7 2 0 81 
29.11.06  Green #18 0 0 14 15 1 0 99 
30.11.06 Low 16 Red #10 0 0 22 26 2 2 107 
30.11.06  Blue #11 0 0 17 15 0 1 101 
30.11.06  Green #12 0 0 15 11 1 1 61 
30.11.06 Low 17 Red #13 0 0 19 20 3 0 87 
30.11.06  Blue #14 4 1 14 22 9 2 105 
30.11.06  Green #15 0 1 18 22 2 0 109 
30.11.06 Low 18 Red #16 0 0 15 17 1 1 73 
30.11.06  Blue #17 1 1 10 22 8 2 108 
30.11.06  Green #18 0 1 15 12 3 1 94 
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 Cage No. Rat  
Date MALES  Time to emerge 
(s)  
No. Head 
pokes 
Defaecation 
(Start Box) 
01.12.06 High 1 Red #1 300.00 5 0 
01.12.06  Blue #2 7.62 1 0 
01.12.06  Green #3 72.16 5 4 
01.12.06 High 2 Red #4 37.66 2 0 
01.12.06  Blue #5 24.97 3 0 
01.12.06  Green #6 56.03 4 0 
01.12.06 High 3 Red #7 22.63 3 0 
01.12.06  Blue #8 74.01 7 0 
01.12.06  Green #9 26.59 2 0 
29.11.06 Control 4  Red #1 61.87 1 0 
29.11.06  Blue #2 55.87 5 0 
29.11.06 Control 5 Blue #4 105.32 1 0 
29.11.06  Green #5 45.16 7 0 
29.11.06 Control 6 Red #6 76.97 3 0 
29.11.06  Blue #7 21.82 1 0 
29.11.06  Green#9 35.40 3 0 
30.11.06 Low 7 Red #1 274.40 4 0 
30.11.06  Blue #2 57.84 5 0 
30.11.06  Green #3 21.65 3 0 
30.11.06 Low 8 Red #4 12.34 1 0 
30.11.06  Blue #5 32.00 6 0 
30.11.06  Green #6 24.50 6 0 
30.11.06 Low 9 Red #7 83.34 6 0 
30.11.06  Blue #8 116.59 5 0 
30.11.06  Green #9 300.00 13 0 
Emergence Test Raw Data. 
Testing period 2. Day 3. 
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Date FEMALES Time to Emerge No. Head 
Pokes 
Defaecation 
(Start Box) 
01.12.06 High 10 Red #10 67.06 5 0 
01.12.06  Blue #11 28.62 3 0 
01.12.06  Green #12 37.22 3 0 
01.12.06 High 11 Red #13 6.78 0 0 
01.12.06  Blue #14 15.35 0 0 
01.12.06  Green #15 37.56 6 0 
01.12.06 High 12 Red #16 28.12 3 0 
01.12.06  Blue #17 48.31 3 0 
01.12.06  Green #18 8.59 2 0 
29.11.06 Control 13 Red #10 6.63 0 0 
29.11.06  Blue #11 5.47 1 0 
29.11.06  Green #12 16.06 2 0 
29.11.06 Control 14 Red #13 300.00 7 0 
29.11.06  Blue #14 29.44 3 0 
29.11.06  Green #15 66.94 9 0 
29.11.06 Control 15 Red #16 34.75 3 0 
29.11.06  Blue #17 47.63 5 0 
29.11.06  Green #18 58.50 3 0 
30.11.06 Low 16 Red #10 300.00 24 0 
30.11.06  Blue #11 19.87 2 0 
30.11.06  Green #12 300.00 11 0 
30.11.06 Low 17 Red #13 36.09 3 0 
30.11.06  Blue #14 15.60 2 0 
30.11.06  Green #15 25.34 3 0 
30.11.06 Low 18 Red #16 61.63 6 0 
30.11.06  Blue #17 59.34 3 0 
30.11.06  Green #18 23.50 2 0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Emergence Test Raw Data. 
Testing period 2. Day 3. 
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Rat # Testing1 Day1 Testing1 Day2 Testing1 Day3 Testing2 Day1 Testing2 Day2 Testing2 Day3 
Centre Corner Centre Corner Centre Corner Centre Corner Centre Corner Centre Corner 
H1R 8 33 0 84 0 69 3 75 0 88 1 63 
H1B 12 48 2 68 4 51 1 38 3 45 5 52 
H1G 13 46 3 71 3 46 9 27 21 25 3 47 
H2R 11 46 0 60 0 54 2 75 2 59 2 71 
H2B 12 50 0 65 3 44 6 60 1 57 6 49 
H2G 13 41 1 58 6 33 5 43 1 47 11 60 
H3R 7 52 2 54 2 62 2 42 6 57 4 69 
H3B 4 44 1 62 0 47 1 52 3 48 1 56 
H3G 9 47 1 64 1 46 1 77 1 72 2 57 
H10R 8 47 0 58 4 51 3 47 7 39 8 32 
H10B 11 53 7 60 5 73 7 56 3 40 7 39 
H10G 12 48 1 48 6 39 7 36 3 48 17 37 
H11R 5 46 6 55 6 32 12 50 12 45 13 42 
H11B 7 53 3 63 2 61 9 53 2 47 0 49 
H11G 9 62 0 80 0 62 1 65 5 47 7 43 
H12R 7 44 8 61 4 53 15 37 6 44 15 37 
H12B 6 59 5 63 8 55 3 67 2 69 5 53 
H12G 4 63 3 50 9 58 3 58 3 52 5 65 
C4R 8 54 0 50 5 28 8 58 3 60 0 50 
C4B 14 51 4 52 1 87 4 55 3 81 1 60 
C4G 5 58 6 48 0 63 - - - - - - 
C5R 7 57 3 43 4 60 11 47 2 50 - - 
C5B 13 46 1 66 1 35 4 45 11 40 14 28 
C5G 24 37 0 58 4 56 10 52 1 25 3 35 
C6R 9 39 0 58 0 94 2 90 0 41 4 69 
C6B 7 49 1 59 5 31 6 44 7 53 3 60 
C6G 10 58 5 60 3 55 5 53 5 57 3 71 
C13R 5 52 1 55 10 37 4 41 6 38 6 43 
C13B 9 43 9 39 6 47 7 48 5 52 6 48 
C13G 10 40 1 64 3 48 14 39 3 48 3 49 
C14R 4 52 8 56 3 68 4 48 4 49 9 37 
C14B 3 52 6 65 7 49 3 43 6 39 9 46 
C14G 5 42 2 29 5 55 3 39 2 37 8 48 
C15R 8 53 0 61 2 67 9 36 2 53 0 48 
C15B 3 46 0 67 1 51 19 38 4 42 3 52 
C15G 8 45 17 39 1 59 12 44 1 48 3 49 
L7R 7 49 0 95 0 55 0 79 1 90 1 84 
L7B 8 42 0 63 7 53 2 58 0 60 4 57 
L7G 8 47 0 45 1 66 0 77 3 62 3 41 
L8R 8 52 0 61 3 78 3 63 6 55 4 66 
L8B 18 33 3 45 1 74 6 32 0 32 5 43 
L8G 10 40 3 42 7 35 5 39 7 26 11 36 
L9R 15 45 0 26 2 47 7 47 6 54 8 38 
L9B 1 69 0 53 3 80 3 61 1 81 4 60 
Behavioural Sampling Raw Data of Open 
Field Centre and Corner Occupancy. 
  
86 
 
 Centre Corner Centre Corner Centre Corner Centre Corner Centre Corner Centre Corner 
L9G 8 46 1 66 0 79 1 58 2 52 5 52 
L16R 0 66 0 66 0 47 1 47 3 49 5 31 
L16B 1 58 1 78 0 67 1 58 6 61 2 52 
L16G 6 55 0 85 3 87 2 76 0 82 6 51 
L17R 0 70 1 79 0 66 0 73 8 38 4 40 
L17B 8 51 7 57 4 50 1 53 6 45 10 29 
L17G 5 31 0 66 6 52 3 58 2 41 3 43 
L18R 2 57 0 70 0 55 9 51 2 42 15 42 
L18B 11 49 6 55 10 36 5 49 6 43 13 28 
L18G 9 50 1 55 4 44 2 70 3 40 5 41 
 
H:   High dose group 
*Number*:  Cage number 
R:   Red 
B:   Blue 
G:   Green 
 
